0000097476-22-000009 | 10-K | XBRL Viewer

Print Document View Excel Document

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 18,344	$ 14,461	$ 14,383
Cost of revenue (COR)	5,968	5,192	5,219
Gross profit	12,376	9,269	9,164
Research and development (R&D)	1,554	1,530	1,544
Selling, general and administrative (SG&A)	1,666	1,623	1,645
Acquisition charges	142	198	288
Restructuring charges/other	54	24	(36)
Operating profit	8,960	5,894	5,723
Other income (expense), net (OI&E)	143	313	175
Interest and debt expense	184	190	170
Income before income taxes	8,919	6,017	5,728
Provision for income taxes	1,150	422	711
Net income	$ 7,769	$ 5,595	$ 5,017
Earnings per common share (EPS):
Basic (in dollars per share)	$ 8.38	$ 6.05	$ 5.33
Diluted (in dollars per share)	$ 8.26	$ 5.97	$ 5.24
Average shares outstanding:
Basic (in shares)	923	921	936
Diluted (in shares)	936	933	952
Diluted EPS:
Net income	$ 7,769	$ 5,595	$ 5,017
Income allocated to RSUs	(33)	(27)	(31)
Income allocated to common stock for diluted EPS	$ 7,736	$ 5,568	$ 4,986

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 7,769	$ 5,595	$ 5,017
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($56), $3 and ($37)	175	(41)	88
Recognized within net income, net of tax effect of ($8), ($9) and ($13)	29	29	38
Prior service credit of defined benefit plans:
Recognized within net income, net of tax effect of $0, $0 and $0	(1)	(1)	0
Other comprehensive income (loss), net of taxes	203	(13)	126
Total comprehensive income	$ 7,972	$ 5,582	$ 5,143

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

- Definition

Amount after tax and reclassification adjustments of other comprehensive income (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

+ Details

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income
Net actuarial losses of defined benefit plans adjustment, tax effect	$ (56)	$ 3	$ (37)
Net actuarial losses of defined benefit plans recognized within net income, tax effect	(8)	(9)	(13)
Prior service credit of defined benefit plans recognized within net income, tax effect	$ 0	$ 0	$ 0

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 4,631	$ 3,107
Short-term investments	5,108	3,461
Accounts receivable, net of allowances of ($8) and ($11)	1,701	1,414
Raw materials	245	180
Work in process	1,067	964
Finished goods	598	811
Inventories	1,910	1,955
Prepaid expenses and other current assets	335	302
Total current assets	13,685	10,239
Property, plant and equipment at cost	7,858	5,781
Accumulated depreciation	(2,717)	(2,512)
Property, plant and equipment	5,141	3,269
Goodwill	4,362	4,362
Deferred tax assets	263	343
Capitalized software licenses	85	122
Overfunded retirement plans	392	246
Other long-term assets	748	770
Total assets	24,676	19,351
Current liabilities:
Current portion of long-term debt	500	550
Accounts payable	653	415
Accrued compensation	775	767
Income taxes payable	121	134
Accrued expenses and other liabilities	520	524
Total current liabilities	2,569	2,390
Long-term debt	7,241	6,248
Underfunded retirement plans	79	131
Deferred tax liabilities	87	90
Other long-term liabilities	1,367	1,305
Total liabilities	11,343	10,164
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued	0	0
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741	1,741	1,741
Paid-in capital	2,630	2,333
Retained earnings	45,919	42,051
Treasury common stock at cost Shares: 2021 - 817 ; 2020 - 821	(36,800)	(36,578)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(157)	(360)
Total stockholders’ equity	13,333	9,187
Total liabilities and stockholders’ equity	$ 24,676	$ 19,351

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Allowance for doubtful accounts receivable, current	$ 8	$ 11
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 25	$ 25
Preferred stock, shares authorized (in shares)	10	10
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	2,400	2,400
Common stock, shares issued (in shares)	1,741	1,741
Treasury stock (in shares)	817	821

Consolidated Statements of Cash Flows - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Cash flows from operating activities

Net income

$ 7,769

$ 5,595

$ 5,017

Adjustments to net income:

Depreciation

755

733

708

Amortization of acquisition-related intangibles

142

198

288

Amortization of capitalized software

Stock compensation

230

224

217

Gains on sales of assets

(57)

(4)

(23)

Deferred taxes

(137)

Increase (decrease) from changes in:

Accounts receivable

(287)

(340)

133

Inventories

216

Prepaid expenses and other current assets

(79)

265

Accounts payable and accrued expenses

(93)

Accrued compensation

(15)

Income taxes payable

(20)

(181)

(193)

Changes in funded status of retirement plans

(9)

Other

(52)

(94)

(35)

Cash flows from operating activities

8,756

6,139

6,649

Cash flows from investing activities

Capital expenditures

(2,462)

(649)

(847)

Proceeds from asset sales

Purchases of short-term investments

(10,124)

(5,786)

(3,444)

Proceeds from short-term investments

8,478

5,545

2,309

Other

(62)

(36)

Cash flows from investing activities

(4,095)

(922)

(1,920)

Cash flows from financing activities

Proceeds from issuance of long-term debt

1,495

1,498

1,491

Repayment of debt

(550)

(500)

(750)

Dividends paid

(3,886)

(3,426)

(3,008)

Stock repurchases

(527)

(2,553)

(2,960)

Proceeds from common stock transactions

^[1]

377

470

539

Other

(46)

(36)

(42)

Cash flows from financing activities

(3,137)

(4,547)

(4,730)

Net change in cash and cash equivalents

1,524

670

(1)

Cash and cash equivalents at beginning of period

3,107

2,437

2,438

Cash and cash equivalents at end of period

$ 4,631

$ 3,107

$ 2,437

[1]	Net of taxes paid for employee shares withheld of $53 million, $53 million and $52 million in 2021, 2020 and 2019, respectively.

Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Common Stock	Paid-in Capital	Retained Earnings	Treasury Common Stock	AOCI
Balance, beginning balance at Dec. 31, 2018		$ 1,741	$ 1,950	$ 37,906	$ (32,130)	$ (473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 5,017			5,017
Dividends declared and paid				(3,008)
Common stock issued for stock-based awards			(55)		594
Stock repurchases					(2,960)
Stock compensation			217
Other comprehensive income (loss), net of taxes	126					126
Dividend equivalents on RSUs				(17)
Other			(2)		1
Balance, ending balance at Dec. 31, 2019		1,741	2,110	39,898	(34,495)	(347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,595			5,595
Dividends declared and paid				(3,426)
Common stock issued for stock-based awards			0		470
Stock repurchases					(2,553)
Stock compensation			224
Other comprehensive income (loss), net of taxes	(13)					(13)
Dividend equivalents on RSUs				(16)
Other			(1)
Balance, ending balance at Dec. 31, 2020	9,187	1,741	2,333	42,051	(36,578)	(360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,769			7,769
Dividends declared and paid				(3,886)
Common stock issued for stock-based awards			67		310
Stock repurchases					(532)
Stock compensation			230
Other comprehensive income (loss), net of taxes	203					203
Dividend equivalents on RSUs				(15)
Balance, ending balance at Dec. 31, 2021	$ 13,333	$ 1,741	$ 2,630	$ 45,919	$ (36,800)	$ (157)

Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Stockholders' Equity [Abstract]
Cash dividends declared per common share (in dollars per share)	$ 4.21	$ 3.72	$ 3.21
Cash dividends paid per common share (in dollars per share)	$ 4.21	$ 3.72	$ 3.21

Description of Business, Including Segment and Geographic Area Information

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Description of business, including segment and geographic area information

We design, make and sell semiconductors to electronics designers and manufacturers all over the world. We have two reportable segments, Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis of similar design and development requirements, product characteristics, manufacturing processes and distribution channels.

•Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog segment consists of two major product lines: Power and Signal Chain.

•Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific tasks and can be optimized for various combinations of performance, power and cost, depending on the application.

We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP® products, calculators and custom ASIC products.

In Other, we also include items that are not used in evaluating the results of or in allocating resources to our segments. Examples of these items include acquisition, integration and restructuring charges (see Note 11); and certain corporate-level items, such as litigation expenses, environmental costs, insurance settlements, and gains and losses from other activities, including asset dispositions. We allocate the remainder of our expenses associated with corporate activities to our operating segments based on specific methodologies, such as percentage of operating expenses or headcount.

Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided.

With the exception of goodwill, we do not identify or allocate assets by operating segment, nor does the chief operating decision maker evaluate operating segments using discrete asset information. We have no material intersegment revenue. The accounting policies of the segments are consistent with those described in the summary of significant accounting policies and practices.

Segment information


	For Years Ended December 31,
	2021		2020		2019
Revenue:
Analog	$	14,050	$	10,886	$	10,223
Embedded Processing	3,049		2,570		2,943
Other	1,245		1,005		1,217
Total revenue	$	18,344	$	14,461	$	14,383

Operating profit:
Analog	$	7,393	$	4,912	$	4,477
Embedded Processing	1,174		743		907
Other	393		239		339
Total operating profit	$	8,960	$	5,894	$	5,723

Geographic area information

The following geographic area information includes revenue, based on product shipment destination, and property, plant and equipment, based on physical location. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products.


	For Years Ended December 31,
	2021		2020		2019
Revenue:
United States	$	1,906	$	1,547	$	1,827
Asia (a)	12,185		9,541		8,650
Europe, Middle East and Africa	2,802		2,249		2,707
Japan	959		734		796
Rest of world	492		390		403
Total revenue	$	18,344	$	14,461	$	14,383

(a)Revenue from products shipped into China was $10.0 billion, $8.0 billion and $7.2 billion in 2021, 2020 and 2019, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.


	December 31,
	2021		2020
Property, plant and equipment:
United States	$	3,648	$	2,036
Asia (a)	1,292		1,005
Europe, Middle East and Africa	47		52
Japan	139		165
Rest of world	15		11
Total property, plant and equipment	$	5,141	$	3,269

(a)Property, plant and equipment at our two sites in the Philippines was $370 million and $333 million as of December 31, 2021 and 2020, respectively. Property, plant and equipment at our sites in China was $570 million and $370 million as of December 31, 2021 and 2020, respectively.

Major customerOne of our end customers accounted for 9%, 10% and 8% of revenue in 2021, 2020 and 2019, respectively, recognized primarily in our Analog segment. No end customer accounted for 10% or more of revenue in 2021 or 2019.

Basis of Presentation and Significant Accounting Policies and Practices

12 Months Ended

Dec. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation and significant accounting policies and practices

Basis of presentation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The basis of these financial statements is comparable for all periods presented herein.

The consolidated financial statements include the accounts of all subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All dollar and share amounts in the financial statements and tables in these notes, except per-share amounts, are presented in millions unless otherwise indicated. We have reclassified certain amounts in the prior periods’ financial statements to conform to the 2021 presentation.

The preparation of financial statements requires the use of estimates from which final results may vary.

Significant accounting policies and practices

Revenue recognition

We generate revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, and recognize revenue when control is transferred. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where required, when the customer has accepted the products. This transfer generally occurs at a point in time upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Payment for sales to customers and distributors is generally due on our standard commercial terms. For sales to distributors, payment is not contingent upon resale of the products.

Revenue from sales of our products that are subject to inventory consignment agreements is recognized at a point in time, when the customer or distributor pulls product from consignment inventory that we store at designated locations. Delivery and transfer of control occur at that point, when title and risk of loss transfers and the customer or distributor becomes obligated to pay for the products pulled from inventory. Until the products are pulled for use or sale by the customer or distributor, we retain control over the products’ disposition, including the right to pull back or relocate the products.

The revenue recognized is adjusted based on allowances, which are prepared on a portfolio basis using a most likely amount methodology based on analysis of historical data and contractual terms. These allowances, which are not material, generally include adjustments for pricing arrangements, product returns, incentives and credit losses. We recognize shipping fees, if any, received from customers in revenue. We include the related shipping and handling costs in cost of revenue. The majority of our customers pay these fees directly to third parties.

Advertising costs

We expense advertising and other promotional costs as incurred. This expense was $27 million, $28 million and $30 million in 2021, 2020 and 2019, respectively.

Income taxes

We account for income taxes using an asset and liability approach. We record the amount of taxes payable or refundable for the current year and the deferred tax assets and liabilities for future tax consequences related to events that have been recognized in the financial statements or tax returns. We record a valuation allowance when it is more likely than not that some or all of the deferred tax assets will not be realized.

Other assessed taxes

Some transactions require us to collect taxes such as sales, value-added and excise taxes from our customers. These transactions are presented in our Consolidated Statements of Income on a net (excluded from revenue) basis.

Leases

We determine if an arrangement is a lease at inception. Leases are included in other long-term assets, accrued expenses and other liabilities, and other long-term liabilities on our Consolidated Balance Sheets.

Lease assets represent our right to use underlying assets for the lease term, and lease liabilities represent our obligations to make lease payments over the lease term. On the commencement date, leases are evaluated for classification, and assets and liabilities are recognized based on the present value of lease payments over the lease term. We use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. Operating lease expense is generally recognized on a straight-line basis over the lease term. Our lease values include options to extend or not to terminate the lease when it is reasonably certain that we will exercise such options.

We have agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with an initial lease term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.

Earnings per share (EPS)

We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.

Computation and reconciliation of earnings per common share are as follows:


	For Years Ended December 31,
	2021					2020					2019
	Net Income		Shares	EPS		Net Income		Shares	EPS		Net Income		Shares	EPS
Basic EPS:
Net income	$	7,769				$	5,595				$	5,017
Income allocated to RSUs	(33)					(27)					(32)
Income allocated to common stock	$	7,736	923	$	8.38	$	5,568	921	$	6.05	$	4,985	936	$	5.33
Dilutive effect of stock compensation plans			13					12					16

Diluted EPS:
Net income	$	7,769				$	5,595				$	5,017
Income allocated to RSUs	(33)					(27)					(31)
Income allocated to common stock	$	7,736	936	$	8.26	$	5,568	933	$	5.97	$	4,986	952	$	5.24

Potentially dilutive securities representing 3 million, 4 million and 6 million shares of common stock that were outstanding in 2021, 2020 and 2019 respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive.

Investments

We present investments on our Consolidated Balance Sheets as cash equivalents, short-term investments or other long-term assets. See Note 6 for additional information.

•Cash equivalents and short-term investments – The primary objectives of our cash equivalent and short-term investment activities are to preserve capital and maintain liquidity while generating appropriate returns. We consider investments in available-for-sale debt securities with maturities of 90 days or less from the date of our investment to be cash equivalents. We consider investments in available-for-sale debt securities with maturities beyond 90 days from the date of our investment as being available for use in current operations and include them in short-term investments.

•Other long-term assets – Long-term investments, which are included within other long-term assets on our Consolidated Balance Sheets, consist of mutual funds, venture capital funds and non-marketable equity securities.

Inventories

Inventories are stated at the lower of cost or estimated net realizable value. Cost is generally computed on a currently adjusted standard cost basis, which approximates cost on a first-in, first-out basis. Standard cost is based on the normal utilization of installed factory capacity. Cost associated with underutilization of capacity is expensed as incurred. Inventory held at consignment locations is included in our finished goods inventory.

We review inventory quarterly for salability and obsolescence. A statistical allowance is provided for inventory considered unlikely to be sold. The statistical allowance is based on an analysis of historical disposal activity, historical customer shipments, as well as estimated future sales. A specific allowance for each material type will be carried if there is a significant event not captured by the statistical allowance. We write off inventory in the period in which disposal occurs.

Property, plant and equipment; acquisition-related intangibles; and other capitalized costs

Property, plant and equipment are stated at cost and depreciated over their estimated useful lives using the straight-line method. Our cost basis includes certain assets acquired in business combinations that were initially recorded at fair value as of the date of acquisition. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements. We amortize acquisition-related intangibles on a straight-line basis over the estimated economic life of the assets. Capitalized software licenses generally are amortized on a straight-line basis over the term of the license. Fully depreciated or amortized assets are written off against accumulated depreciation or amortization.

Impairments of long-lived assets

We regularly review whether facts or circumstances exist that indicate the carrying values of property, plant and equipment or other long-lived assets, including intangible assets, are impaired. We assess the recoverability of assets by comparing the projected undiscounted net cash flows associated with those assets to their respective carrying amounts. Any impairment charge is based on the excess of the carrying amount over the fair value of those assets. Fair value is determined by available market valuations, if applicable, or by discounted cash flows.

Goodwill

Goodwill is reviewed for impairment annually in the fourth quarter or more frequently if certain impairment indicators arise. We perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If, as a result of the qualitative assessment, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then we perform the quantitative goodwill impairment test. See Note 11 for additional information.

Foreign currency

The functional currency for our non-U.S. subsidiaries is the U.S. dollar. Accounts recorded in currencies other than the U.S. dollar are remeasured into the functional currency. Current assets (except inventories), deferred taxes, other long-term assets, current liabilities and long-term liabilities are remeasured at exchange rates in effect at the end of each reporting period. Property, plant and equipment with associated depreciation and inventories are valued at historical exchange rates. Revenue and expense accounts other than depreciation for each month are calculated at the appropriate daily rate of exchange. Currency exchange gains and losses from remeasurement are credited or charged to OI&E.

Derivatives and hedging

We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.

We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A.

In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt.

The results of these derivative transactions were not material. We do not use derivatives for speculative or trading purposes.

Stock Compensation

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Stock compensation

We have stock options outstanding to participants under long-term incentive plans. The option price per share may not be less than the fair market value of our common stock on the date of the grant. The options have a 10-year term, generally vest ratably over four years and continue to vest after the option recipient retires.

We also have RSUs outstanding to participants under long-term incentive plans. Each RSU represents the right to receive one share of TI common stock, issued on the vesting date, which is generally four years after the date of grant. RSUs continue to vest after the recipient retires. Holders of RSUs receive an annual cash payment equivalent to the dividends paid on our common stock. The fair value per share of RSUs is generally determined based on the closing price of our common stock on the date of grant.

We have options and RSUs outstanding to non-employee directors under director compensation plans. The plans generally provide for annual grants of stock options and RSUs, a one-time grant of RSUs to each new non-employee director and the issuance of TI common stock upon the distribution of stock units credited to director deferred compensation accounts.

We also have an employee stock purchase plan (ESPP) under which options are offered to all eligible employees in amounts based on a percentage of the employee’s compensation, subject to a cap. Under the plan, the option price per share is 85% of the fair market value on the exercise date. As of December 31, 2021, 33 million shares remain available for future issuance under this plan.

Total stock compensation expense recognized is as follows:


	For Years Ended December 31,
	2021		2020		2019
COR	$	21	$	21	$	21
R&D	67		68		66
SG&A	134		135		130
Restructuring charges/other	8		—		—
Total	230		224		217

These amounts include expenses related to non-qualified stock options, RSUs and stock options offered under our ESPP and are net of estimated forfeitures.

We recognize compensation expense for non-qualified stock options and RSUs on a straight-line basis over the minimum service period required for vesting of the award, adjusting for estimated forfeitures based on historical activity. Awards issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis. Options issued under our ESPP are expensed over a three-month period.

As of December 31, 2021, total future compensation related to equity awards not yet recognized in our Consolidated Statements of Income was $271 million, which we expect to recognize over a weighted average period of 1.7 years.

Fair value methods and assumptions

We account for all awards granted under our various stock compensation plans at fair value.

We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions:


	For Years Ended December 31,
	2021			2020			2019
Weighted average grant date fair value, per share	$	40.78		$	25.55		$	22.08
Weighted average assumptions used:
Expected volatility	32		%	26		%	26		%
Expected lives (in years)	6.7			6.8			7.1
Risk-free interest rates	0.72		%	1.53		%	2.66		%
Expected dividend yields	2.41		%	2.76		%	2.95		%

We use market-based measures of implied volatility to determine expected volatility on all options granted. We determine expected lives of options based on the historical option exercise experience of our option holders using a rolling 10-year average.

Expected dividend yields are based on the annualized approved quarterly dividend rate and the current market price of our common stock at the time of grant. No assumption for a future dividend rate change is included unless there is an approved plan to change the dividend in the near term.

Long-term incentive and director compensation plans

Stock option and RSU transactions under our long-term incentive and director compensation plans are as follows:


	Stock Options			RSUs
	Shares	Weighted Average Exercise Price per Share		Shares	Weighted Average Grant Date Fair Value per Share
Outstanding grants, December 31, 2020	28	$	79.69	5	$	100.80
Granted	3	169.52		1	176.08
Stock options exercised/RSUs vested	(6)	65.89		(2)	81.31
Outstanding grants, December 31, 2021 (a)	25	91.58		4	124.80

(a) Forfeited and expired shares were not material.


	For Years Ended December 31,
	2021		2020		2019
Weighted average grant date fair value per share for RSUs	$	176.08	$	130.59	$	106.58
Total grant date fair value of shares vested for RSUs	$	115	$	110	$	125
Aggregate intrinsic value of options exercised	$	611	$	681	$	819

As of December 31, 2021, 37 million shares remain available for future issuance under these plans.

Summarized information about stock options outstanding as of December 31, 2021, is as follows:


		Stock Options Outstanding
Exercise Price Range		Number Outstanding (Shares)	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price per Share
$	28.13 to 193.58	25	5.5	$	91.58


	Options Fully Vested and Expected to Vest (a)		Options Exercisable
Options outstanding (shares)	25		16
Weighted average remaining contractual life (in years)	5.5		4.2
Weighted average exercise price per share	$	90.97	$	69.43
Intrinsic value	$	2,408	$	1,952

(a)Includes effects of expected forfeitures. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $2.42 billion.

Effect on shares outstanding and treasury shares

Treasury shares were acquired in connection with the board-authorized stock repurchase program. As of December 31, 2021, $10.10 billion of stock repurchase authorizations remain, and no expiration date has been specified.

Our practice is to issue shares of common stock from treasury shares upon exercise of stock options, distribution of director deferred compensation and vesting of RSUs. The following table reflects the changes in our treasury shares:


	For Years Ended December 31,
	2021	2020	2019
Balance, January 1	821	809	796
Repurchases	3	23	27
Shares issued	(7)	(11)	(14)
Balance, December 31	817	821	809

The effects on cash flows are as follows:


	For Years Ended December 31,
	2021		2020		2019
Proceeds from common stock transactions (a)	$	377	$	470	$	539

Tax benefit realized from stock compensation	$	175	$	195	$	224
Reduction to deferred tax asset	(39)		(44)		(49)
Excess tax benefit for stock compensation	$	136	$	151	$	175

(a)Net of taxes paid for employee shares withheld of $53 million, $53 million and $52 million in 2021, 2020 and 2019, respectively.

Income Taxes

12 Months Ended

Dec. 31, 2021

Income Tax Disclosure [Abstract]

Income taxes

Income taxesIncome before income taxes is comprised of the following components:


	For Years Ended December 31,
	2021		2020		2019
U.S.	$	7,998	$	5,210	$	4,915
Non-U.S.	921		807		813
Total	$	8,919	$	6,017	$	5,728

Provision for income taxes is comprised of the following components:


	For Years Ended December 31,
	2021						2020						2019
	Current		Deferred		Total		Current		Deferred		Total		Current		Deferred		Total
U.S. federal	$	948	$	(23)	$	925	$	357	$	(122)	$	235	$	483	$	25	$	508
Non-U.S.	169		38		207		192		(15)		177		135		56		191
U.S. state	18		—		18		10		—		10		12		—		12
Total	$	1,135	$	15	$	1,150	$	559	$	(137)	$	422	$	630	$	81	$	711

Principal reconciling items from the U.S. statutory income tax rate to the effective tax rate (provision for income taxes as a percentage of income before income taxes) are as follows:


	For Years Ended December 31,
	2021		2020		2019
U.S. statutory income tax rate	21.0	%	21.0	%	21.0	%
U.S. tax benefit for foreign derived intangible income	(6.1)		(6.1)		(4.9)
U.S. excess tax benefit for stock compensation	(1.5)		(2.5)		(3.1)
U.S. R&D tax credit	(0.9)		(1.3)		(1.4)
Impact of changes in uncertain tax positions	(0.2)		(4.0)		(0.1)
Other	0.6		(0.1)		0.9
Effective tax rate	12.9	%	7.0	%	12.4	%

The earnings represented by non-cash operating assets, such as fixed assets and inventory, will continue to be permanently reinvested outside the United States. Provisions of the U.S. Tax Cuts and Jobs Act (the Tax Act), such as the one-time tax on indefinitely reinvested earnings and the global intangible low-taxed income (GILTI) tax for years beginning in 2018, eliminate any additional U.S. taxation resulting from repatriation of earnings of non-U.S. subsidiaries to the United States. Consequently, no U.S. tax provision has been made for the future remittance of these earnings. However, withholding or distribution taxes in certain non-U.S. jurisdictions will be incurred upon repatriation of available cash to the United States. A provision has been made for deferred taxes on these undistributed earnings to the extent that repatriation of the available cash to the United States is expected to result in a tax liability. As of December 31, 2021, we have no basis differences that would result in material unrecognized deferred tax liabilities.

We have made an allowable policy election to account for the effects of GILTI as a component of income tax expense in the period in which the tax is incurred.

The primary components of deferred tax assets and liabilities are as follows:


	December 31,
	2021		2020
Deferred tax assets:
Accrued expenses	$	209	$	180
Deferred loss and tax credit carryforwards	207		207
Stock compensation	110		106
Inventories and related reserves	74		105
Retirement costs for defined benefit and retiree health care	—		44
Other	40		3
Total deferred tax assets, before valuation allowance	640		645
Valuation allowance	(188)		(179)
Total deferred tax assets, after valuation allowance	452		466
Deferred tax liabilities:
Property, plant and equipment	(197)		(116)
International earnings	(38)		(44)
Retirement costs for defined benefit and retiree health care	(15)		—
Acquisition-related intangibles and fair-value adjustments	(12)		(40)
Other	(14)		(13)
Total deferred tax liabilities	(276)		(213)
Net deferred tax asset	$	176	$	253

The deferred tax assets and liabilities based on tax jurisdictions are presented on our Consolidated Balance Sheets as follows:


	December 31,
	2021		2020
Deferred tax assets	$	263	$	343
Deferred tax liabilities	(87)		(90)
Net deferred tax asset	$	176	$	253

We make an ongoing assessment regarding the realization of U.S. and non-U.S. deferred tax assets. This assessment is based on our evaluation of relevant criteria, including the existence of deferred tax liabilities that can be used to absorb deferred tax assets, taxable income in prior carryback years and expectations for future taxable income. Valuation allowances increased $9 million in 2021, decreased $1 million in 2020 and increased $8 million in 2019. These changes had no impact to net income in 2021, 2020 or 2019.

We have no material tax loss carryforwards as of December 31, 2021.

Cash payments made for income taxes, net of refunds, were $1.20 billion, $720 million and $570 million in 2021, 2020 and 2019, respectively.

Uncertain tax positions

We operate in a number of tax jurisdictions, and our income tax returns are subject to examination by tax authorities in those jurisdictions who may challenge any item on these tax returns. Because the matters challenged by authorities are typically complex, their ultimate outcome is uncertain. Before any benefit can be recorded in our financial statements, we must determine that it is “more likely than not” that a tax position will be sustained by the appropriate tax authorities. We recognize accrued interest related to uncertain tax positions and penalties as components of OI&E.

The changes in the total amounts of uncertain tax positions are as follows:


	2021		2020		2019
Balance, January 1	$	89	$	303	$	286
Additions based on tax positions related to the current year	2		3		3
Additions for tax positions of prior years	7		35		63
Reductions for tax positions of prior years	(6)		(249)		(41)
Settlements with tax authorities	(23)		—		(8)
Expiration of the statute of limitations for assessing taxes	—		(3)		—
Balance, December 31	$	69	$	89	$	303

Interest income (expense) recognized in the year ended December 31	$	(5)	$	39	$	9

Interest payable as of December 31	$	13	$	8	$	44

The liability for uncertain tax positions is a component of other long-term liabilities on our Consolidated Balance Sheets.

All of the $69 million and $89 million liabilities for uncertain tax positions as of December 31, 2021 and 2020, respectively, are comprised of positions that, if recognized, would lower the effective tax rate. If these liabilities are ultimately realized, $2 million of existing deferred tax assets in 2020 would also be realized. Reductions for tax positions of prior years in 2020 include a $249 million tax benefit for the effective settlement of a depreciation-related uncertain tax position. Accrued interest of $46 million related to this uncertain tax position was reversed and included in OI&E.

As of December 31, 2021, the statute of limitations remains open for U.S. federal tax returns for 2017 and following years. Certain tax treaty procedures for relief from double taxation remain pending for U.S. federal tax returns for the years 2011 through 2020.

In non-U.S. jurisdictions, the years open to audit represent the years still open under the statute of limitations. With respect to major jurisdictions outside the United States, our subsidiaries are no longer subject to income tax audits for years before 2012.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Financial Instruments and Risk Concentration	12 Months Ended
Financial Instruments and Risk Concentration	Dec. 31, 2021
Risks and Uncertainties [Abstract]
Financial instruments and risk concentration	Financial instruments and risk concentration Financial instruments We hold derivative financial instruments such as forward foreign currency exchange contracts, the fair value of which was not material as of December 31, 2021. Our forward foreign currency exchange contracts outstanding as of December 31, 2021, had a notional value of $313 million to hedge our non-U.S. dollar net balance sheet exposures, including $127 million to sell Japanese yen, $82 million to sell British pounds and $42 million to sell euros. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. Our postretirement plan assets are carried at fair value or net asset value per share. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of December 31, 2021, the carrying value of long-term debt, including the current portion, was $7.74 billion, and the estimated fair value was $8.38 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 6 for a description of fair value and the definition of Level 2 inputs. Risk concentration We are subject to counterparty risks from financial institutions, customers and issuers of debt securities. Financial instruments that could subject us to concentrations of credit risk are primarily cash deposits, cash equivalents, short-term investments and accounts receivable. To manage our credit risk exposure, we place cash investments in investment-grade debt securities and limit the amount of credit exposure to any one issuer. We also limit counterparties on cash deposits and financial derivative contracts to financial institutions with investment-grade ratings. Concentrations of credit risk with respect to accounts receivable are limited due to our large number of customers and their dispersion across different industries and geographic areas. We maintain allowances for expected returns, disputes, adjustments, incentives and credit losses. These allowances are deducted from accounts receivable on our Consolidated Balance Sheets. Accounts receivable allowances changed to reflect amounts charged (credited) to operating results by ($3) million, $3 million and ($11) million in 2021, 2020 and 2019, respectively.

Valuation of Debt and Equity Investments and Certain Liabilities

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Valuation of debt and equity investments and certain liabilities

Investments measured at fair value

Money market funds, available-for-sale debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.

Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.

Other investments

Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results.

Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E.

Details of our investments are as follows:


	December 31, 2021						December 31, 2020
	Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments		Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments
Measured at fair value:
Money market funds	$	1,824	$	—	$	—	$	886	$	—	$	—
Corporate obligations	1,060		1,070		—		256		257		—
U.S. government and agency securities	642		3,388		—		1,340		3,054		—
Non-U.S. government and agency securities	300		650		—		—		150		—
Mutual funds	—		—		16		—		—		18
Total	3,826		5,108		16		2,482		3,461		18

Other measurement basis:
Equity-method investments	—		—		42		—		—		27
Non-marketable equity investments	—		—		4		—		—		4
Cash on hand	805		—		—		625		—		—
Total	$	4,631	$	5,108	$	62	$	3,107	$	3,461	$	49

As of December 31, 2021 and 2020, unrealized gains and losses associated with our available-for-sale investments were not material. We did not recognize any credit losses related to available-for-sale investments in 2021, 2020 or 2019. All of our debt securities classified as available for sale as of December 31, 2021, have maturities within one year.

In 2021, 2020 and 2019, the proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $8.48 billion, $5.29 billion and $2.31 billion, respectively. Gross realized gains and losses from these sales were not material.

In 2020, we entered into total return swaps to economically hedge the variability of certain deferred compensation obligations to employees. As a result, in 2020, we received proceeds of $253 million from the sale of investments in mutual funds that were previously being utilized to offset this exposure.

Fair-value considerations

We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements.

•Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.

•Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets.

•Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of December 31, 2021 and 2020, we had no Level 3 assets or liabilities.

The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.


	December 31, 2021						December 31, 2020
	Level 1		Level 2		Total		Level 1		Level 2		Total
Assets:
Money market funds	$	1,824	$	—	$	1,824	$	886	$	—	$	886
Corporate obligations	—		2,130		2,130		—		513		513
U.S. government and agency securities	3,629		401		4,030		4,394		—		4,394
Non-U.S. government and agency securities	—		950		950		—		150		150
Mutual funds	16		—		16		18		—		18
Total assets	$	5,469	$	3,481	$	8,950	$	5,298	$	663	$	5,961

Liabilities:
Deferred compensation	$	395	$	—	$	395	$	350	$	—	$	350
Total liabilities	$	395	$	—	$	395	$	350	$	—	$	350

Postretirement Benefit Plans

12 Months Ended

Dec. 31, 2021

Retirement Benefits [Abstract]

Postretirement benefit plans

Plan descriptions

We have various employee retirement plans, including defined contribution, defined benefit and retiree health care benefit plans. For qualifying employees, we offer deferred compensation arrangements.

U.S. retirement plans

Our principal retirement plans in the United States are a defined contribution plan, an enhanced defined contribution plan and qualified and non-qualified defined benefit pension plans. The defined benefit plans were closed to new participants in 1997, and then current participants were allowed to make a one-time election to continue accruing a benefit in the plans or to cease accruing a benefit and instead to participate in the enhanced defined contribution plan.

Both defined contribution plans offer an employer-matching savings option that allows employees to make pretax and post-tax contributions to various investment choices. Employees who elected to continue accruing a benefit in the qualified defined benefit pension plans may also participate in the defined contribution plan, where employer-matching contributions are provided for up to 2% of the employee’s annual eligible earnings. Employees who elected not to continue accruing a benefit in the defined benefit pension plans and employees hired after November 1997 and through December 31, 2003, may participate in the enhanced defined contribution plan. This plan provides for a fixed employer contribution of 2% of the employee’s annual eligible earnings, plus an employer-matching contribution of up to 4% of the employee’s annual eligible earnings. Employees hired after December 31, 2003, do not receive the fixed employer contribution of 2% of the employee’s annual eligible earnings.

As of December 31, 2021 and 2020, as a result of employees’ elections, TI’s U.S. defined contribution plans held shares of TI common stock totaling 6 million shares and 7 million shares valued at $1.16 billion and $1.12 billion, respectively. Dividends paid on these shares in both 2021 and 2020 were $27 million. Effective April 1, 2016, the TI common stock fund was frozen to new contributions or transfers into the fund.

Our aggregate expense for the U.S. defined contribution plans was $63 million in 2021 and $61 million in 2020 and 2019.

The defined benefit pension plans include employees still accruing benefits, as well as employees and participants who no longer accrue service-related benefits, but instead, may participate in the enhanced defined contribution plan. Benefits under the qualified defined benefit pension plan are determined using a formula based on years of service and the highest five consecutive years of compensation. We intend to contribute amounts to this plan to meet the minimum funding requirements of applicable local laws and regulations, plus such additional amounts as we deem appropriate. The non-qualified defined benefit plans are unfunded and closed to new participants.

U.S. retiree health care benefit plan

U.S. employees who meet eligibility requirements are offered medical coverage during retirement. We make a contribution toward the cost of those retiree medical benefits for certain retirees and their dependents. The contribution rates are based upon various factors, the most important of which are an employee’s date of hire, date of retirement, years of service and eligibility for Medicare benefits. The balance of the cost is borne by the plan’s participants. Employees hired after January 1, 2001, are responsible for the full cost of their medical benefits during retirement.

Non-U.S. retirement plans

We provide retirement coverage for non-U.S. employees, as required by local laws or to the extent we deem appropriate, through a number of defined benefit and defined contribution plans. Retirement benefits are generally based on an employee’s years of service and compensation. Funding requirements are determined on an individual country and plan basis and are subject to local country practices and market circumstances.

As of December 31, 2021 and 2020, as a result of employees’ elections, TI’s non-U.S. defined contribution plans held TI common stock valued at $38 million and $36 million, respectively. Dividends paid on these shares of TI common stock in 2021 and 2020 were not material.

Effects on our Consolidated Statements of Income and Balance Sheets

Expenses related to defined benefit and retiree health care benefit plans are as follows:


	U.S. Defined Benefit						U.S. Retiree Health Care						Non-U.S. Defined Benefit
	2021		2020		2019		2021		2020		2019		2021		2020		2019
Service cost	$	21	$	18	$	18	$	3	$	3	$	3	$	36	$	34	$	31
Interest cost	30		31		38		10		13		14		37		38		43
Expected return on plan assets	(31)		(36)		(41)		(9)		(12)		(14)		(81)		(78)		(86)
Amortization of prior service cost (credit)	—		—		—		(2)		(2)		(1)		1		1		1
Recognized net actuarial loss	15		7		9		—		—		—		7		14		29
Net periodic benefit costs	35		20		24		2		2		2		—		9		18
Settlement losses	13		16		10		—		—		—		2		1		3
Total, including other postretirement losses	$	48	$	36	$	34	$	2	$	2	$	2	$	2	$	10	$	21

All defined benefit and retiree health care benefit plan expense components other than service cost are recognized in OI&E in our Consolidated Statements of Income. Service cost is recognized within operating profit.

For the U.S. qualified pension and retiree health care plans, the expected return on plan assets component of net periodic benefit cost is based upon a market-related value of assets. In accordance with U.S. GAAP, the market-related value of assets is the fair value adjusted by a smoothing technique whereby certain gains and losses are phased in over a period of three years.

Changes in the benefit obligations and plan assets for defined benefit and retiree health care benefit plans are as follows:


	U.S. Defined Benefit				U.S. Retiree Health Care				Non-U.S. Defined Benefit
	2021		2020		2021		2020		2021		2020
Change in plan benefit obligation
Benefit obligation at beginning of year:	$	1,097	$	960	$	389	$	359	$	2,868	$	2,581
Service cost	21		18		3		3		36		34
Interest cost	30		31		10		13		37		38
Participant contributions	—		—		14		13		9		7
Benefits paid	(12)		(12)		(38)		(39)		(101)		(95)
Settlements	(162)		(94)		—		—		(12)		(8)

Actuarial loss (gain)	(79)		194		(18)		40		(111)		143
Plan amendments	—		—		—		—		—		1
Effects of exchange rate changes	—		—		—		—		(152)		167
Benefit obligation at end of year	$	895	$	1,097	$	360	$	389	$	2,574	$	2,868

Change in plan assets
Fair value of plan assets at beginning of year:	$	1,061	$	987	$	389	$	356	$	3,008	$	2,661
Actual return on plan assets	37		164		19		58		75		260
Employer contributions (qualified plans)	—		—		1		1		7		11
Employer contributions (non-qualified plans)	10		16		—		—		—		—
Participant contributions	—		—		14		13		9		7
Benefits paid	(12)		(12)		(38)		(39)		(101)		(95)
Settlements	(162)		(94)		—		—		(12)		(8)
Effects of exchange rate changes	—		—		—		—		(173)		172

Fair value of plan assets at end of year	$	934	$	1,061	$	385	$	389	$	2,813	$	3,008

Funded status at end of year	$	39	$	(36)	$	25	$	—	$	239	$	140

Changes in actuarial gains and losses in the projected benefit obligations are generally driven by discount rate movement.

Amounts recognized on our Consolidated Balance Sheets as of December 31, are as follows:


	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit		Total
2021
Overfunded retirement plans	$	73	$	28	$	291	$	392
Accrued expenses and other liabilities & other long-term liabilities	(5)		—		(5)		(10)
Underfunded retirement plans	(29)		(3)		(47)		(79)
Funded status at end of 2021	$	39	$	25	$	239	$	303

2020
Overfunded retirement plans	$	9	$	3	$	234	$	246
Accrued expenses and other liabilities & other long-term liabilities	(6)		—		(5)		(11)
Underfunded retirement plans	(39)		(3)		(89)		(131)
Funded status at end of 2020	$	(36)	$	—	$	140	$	104

Contributions to the plans meet or exceed all minimum funding requirements. We expect to contribute about $10 million to our retirement benefit plans in 2022.

Accumulated benefit obligations, which are generally less than the projected benefit obligations as they exclude the impact of future salary increases, were $820 million and $992 million as of December 31, 2021 and 2020, respectively, for the U.S. defined benefit plans, and $2.47 billion and $2.72 billion as of December 31, 2021 and 2020, respectively, for the non-U.S. defined benefit plans.

The change in AOCI is as follows:


	U.S. Defined Benefit		U.S. Retiree Health Care				Non-U.S. Defined Benefit				Total
	Net Actuarial Loss		Net Actuarial Loss		Prior Service Credit		Net Actuarial Loss		Prior Service Credit		Net Actuarial Loss		Prior Service Credit
AOCI balance, net of taxes, December 31, 2020	$	125	$	(8)	$	(2)	$	242	$	1	$	359	$	(1)
Changes in AOCI by category:
Adjustments	(84)		(28)		—		(119)		—		(231)		—
Recognized within net income	(28)		—		2		(9)		(1)		(37)		1
Tax effect	23		6		(1)		35		1		64		—
Total change to AOCI	(89)		(22)		1		(93)		—		(204)		1
AOCI balance, net of taxes, December 31, 2021	$	36	$	(30)	$	(1)	$	149	$	1	$	155	$	—

Information on plan assets

We report and measure the plan assets of our defined benefit pension and other postretirement plans at fair value. The tables below set forth the fair value of our plan assets using the same three-level hierarchy of fair-value inputs described in Note 6.


	December 31, 2021
	Level 1		Level 2		Other (a)		Total
Assets of U.S. defined benefit plan:
Fixed income securities and cash equivalents	$	—	$	—	$	655	$	655
Equity securities	—		—		279		279
Total	$	—	$	—	$	934	$	934

Assets of U.S. retiree health care plan:
Fixed income securities and cash equivalents	$	10	$	—	$	238	$	248
Equity securities	—		—		137		137
Total	$	10	$	—	$	375	$	385

Assets of non-U.S. defined benefit plans:
Fixed income securities and cash equivalents	$	71	$	104	$	2,045	$	2,220
Equity securities	49		2		542		593
Total	$	120	$	106	$	2,587	$	2,813

(a)Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents.


	December 31, 2020
	Level 1		Level 2		Other (a)		Total
Assets of U.S. defined benefit plan:
Fixed income securities and cash equivalents	$	—	$	—	$	743	$	743
Equity securities	—		—		318		318
Total	$	—	$	—	$	1,061	$	1,061

Assets of U.S. retiree health care plan:
Fixed income securities and cash equivalents	$	29	$	—	$	222	$	251
Equity securities	—		—		138		138
Total	$	29	$	—	$	360	$	389

Assets of non-U.S. defined benefit plans:
Fixed income securities and cash equivalents	$	69	$	146	$	2,063	$	2,278
Equity securities	43		2		685		730
Total	$	112	$	148	$	2,748	$	3,008

(a)Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents.

The investments in our major benefit plans largely consist of low-cost, broad-market index funds to mitigate risks of concentration within market sectors. Our investment policy is designed to better match the interest rate sensitivity of the plan assets and liabilities. The appropriate mix of equity and bond investments is determined primarily through the use of detailed asset-liability modeling studies that look to balance the impact of changes in the discount rate against the need to provide asset growth to cover future service cost. Most of our plans around the world have a greater proportion of fixed income securities with return characteristics that are more closely aligned with changes in the liabilities caused by discount rate volatility.

Assumptions and investment policies


	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit
	2021	2020	2021	2020	2021	2020
Weighted average assumptions used to determine benefit obligations:
Discount rate	2.74%	2.81%	3.05%	2.74%	1.57%	1.31%
Long-term pay progression	3.70%	3.70%	n/a	n/a	3.15%	3.15%

Weighted average assumptions used to determine net periodic benefit cost:
Discount rate	2.95%	3.42%	2.74%	3.63%	1.31%	1.46%
Long-term rate of return on plan assets	3.50%	4.00%	3.10%	3.50%	2.82%	2.93%
Long-term pay progression	3.70%	3.30%	n/a	n/a	3.15%	3.06%

We utilize a variety of methods to select an appropriate discount rate depending on the depth of the corporate bond market in the country in which the benefit plan operates. In the United States, we use a settlement approach whereby a portfolio of bonds is selected from the universe of actively traded high-quality U.S. corporate bonds. The selected portfolio is designed to provide cash flows sufficient to pay the plan’s expected benefit payments when due. The resulting discount rate reflects the rate of return of the selected portfolio of bonds. For our non-U.S. locations with a sufficient number of actively traded high-quality bonds, an analysis is performed in which the projected cash flows from the defined benefit plans are discounted against a yield curve constructed with an appropriate universe of high-quality corporate bonds available in each country. In this manner, a present value is developed. The discount rate selected is the single equivalent rate that produces the same present value. For countries that lack a sufficient corporate bond market, a government bond index is used to establish the discount rate.

Assumptions for the expected long-term rate of return on plan assets are based on future expectations for returns for each asset class and the effect of periodic target asset allocation rebalancing. We adjust the results for the payment of reasonable expenses of the plan from plan assets. We believe our assumptions are appropriate based on the investment mix and long-term nature of the plans’ investments. Assumptions used for the non-U.S. defined benefit plans reflect the different economic environments within the various countries.

The target allocation ranges for the plans that hold a substantial majority of the defined benefit assets are as follows:

U.S. Defined Benefit

U.S. Retiree Health Care

Non-U.S. Defined Benefit

Fixed income securities and cash equivalents

65% – 80%

60% – 100%

Equity securities

20% – 35%

0% – 40%

We rebalance the plans’ investments when they are outside the target allocation ranges.

Weighted average asset allocations as of December 31 are as follows:


	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit
	2021	2020	2021	2020	2021	2020
Fixed income securities and cash equivalents	70%	70%	64%	65%	79%	76%
Equity securities	30%	30%	36%	35%	21%	24%

None of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock.

The following assumed future benefit payments to plan participants in the next 10 years are used to measure our benefit obligations. Almost all of the payments, which may vary significantly from these assumptions, will be made from plan assets and not from company assets.


	2022		2023		2024		2025		2026		2027 – 2031
U.S. Defined Benefit	$	89	$	96	$	87	$	87	$	87	$	391
U.S. Retiree Health Care	28		27		26		25		24		108
Non-U.S. Defined Benefit	99		101		103		105		107		566

Assumed health care cost trend rates for the U.S. retiree health care benefit plan as of December 31 are as follows:


	2021	2020
Assumed health care cost trend rate for next year	6.50%	6.75%
Ultimate trend rate	5.00%	5.00%
Year in which ultimate trend rate is reached	2028	2028

Deferred compensation plans

We have deferred compensation plans that allow U.S. employees whose base salary and management responsibility exceed a certain level to defer receipt of a portion of their cash compensation. Payments under these plans are made based on the participant’s distribution election and plan balance. Participants can earn a return on their deferred compensation based on notional investments in the same investment funds that are offered in our defined contribution plans.

As of December 31, 2021, our liability to participants of the deferred compensation plans was $395 million and is recorded in other long-term liabilities on our Consolidated Balance Sheets. This amount reflects the accumulated participant deferrals and earnings thereon as of that date. We utilize total return swaps and investments in mutual funds that serve as economic hedges of our exposure to changes in the fair value of these liabilities. We record changes in the fair value of the liability and the related total return swaps and mutual funds in SG&A, as discussed in Note 6. As of December 31, 2021, we held $16 million in mutual funds related to these plans that are recorded in long-term investments on our Consolidated Balance Sheets.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

Debt and Lines of Credit

12 Months Ended

Dec. 31, 2021

Debt Disclosure [Abstract]

Debt and lines of credit

Short-term borrowings

We maintain a line of credit to support commercial paper borrowings, if any, and to provide additional liquidity through bank loans. As of December 31, 2021, we had a variable-rate revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $2 billion until March 2024. As of December 31, 2021, our credit facility was undrawn, and we had no commercial paper outstanding.

Long-term debt

In February 2021, we retired $550 million of maturing debt.

In September 2021, we issued three series of senior unsecured notes for an aggregate principal amount of $1.5 billion, consisting of $500 million of 1.125% notes due in 2026, $500 million of 1.90% notes due in 2031 and $500 million of 2.70% notes due in 2051. We incurred $10 million of issuance costs. The proceeds of the offering were $1.5 billion, net of the original issuance discounts, which will be used for general corporate purposes.

In March 2020, we issued a principal amount of $750 million of fixed-rate, long-term debt due in 2025. We incurred $4 million of issuance costs. The proceeds of the offering were $749 million, net of the original issuance discount, and were used for general corporate purposes and the repayment of maturing debt.

In April 2020, we retired $500 million of maturing debt.

In May 2020, we issued a principal amount of $750 million of fixed-rate, long-term debt due in 2030. We incurred $5 million of issuance costs. The proceeds of the offering were $749 million, net of the original issuance discount, and were used for general corporate purposes.

In March 2019, we issued a principal amount of $750 million of fixed-rate, long-term debt due in 2039. We incurred $7 million of issuance costs. The proceeds of the offering were $743 million, net of the original issuance discount, and were used for general corporate purposes.

In August 2019, we retired $750 million of maturing debt.

In September 2019, we issued a principal amount of $750 million of fixed-rate, long-term debt due in 2029. We incurred $5 million of issuance costs. The proceeds of the offering were $748 million, net of the original issuance discount, and were used for general corporate purposes.

Long-term debt outstanding is as follows:


	December 31,
	2021		2020
Notes due 2021 at 2.75%	$	—	$	550
Notes due 2022 at 1.85%	500		500
Notes due 2023 at 2.25%	500		500
Notes due 2024 at 2.625%	300		300
Notes due 2025 at 1.375%	750		750
Notes due 2026 at 1.125%	500		—
Notes due 2027 at 2.90%	500		500
Notes due 2029 at 2.25%	750		750
Notes due 2030 at 1.75%	750		750
Notes due 2031 at 1.90%	500		—
Notes due 2039 at 3.875%	750		750
Notes due 2048 at 4.15%	1,500		1,500
Notes due 2051 at 2.70%	500		—
Total debt	7,800		6,850
Net unamortized discounts, premiums and issuance costs	(59)		(52)
Total debt, including net unamortized discounts, premiums and issuance costs	7,741		6,798
Current portion of long-term debt	(500)		(550)
Long-term debt	$	7,241	$	6,248

Interest and debt expense was $184 million, $190 million and $170 million in 2021, 2020 and 2019, respectively. This was net of the amortized discounts, premiums and issuance costs. Cash payments for interest on long-term debt were $181 million, $182 million and $156 million in 2021, 2020 and 2019, respectively. Capitalized interest was not material.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Leases

12 Months Ended

Dec. 31, 2021

Leases [Abstract]

Leases

We conduct certain operations in leased facilities and also lease a portion of our data processing and other equipment. In addition, certain long-term supply agreements to purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require us to pay real estate taxes, insurance and maintenance costs.

Our leases are included as a component of the following balance sheet lines:


	December 31,
	2021		2020
Other long-term assets	$	465	$	319

Accrued expenses and other liabilities	$	82	$	72
Other long-term liabilities	383		249

Details of our operating leases are as follows:


	For Years Ended December 31,
	2021		2020		2019
Lease cost related to lease liabilities	$	69	$	70	$	66
Variable lease cost	56		36		41

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for lease cost	$	61	$	59	$	60

Lease assets obtained in exchange for new lease liabilities	$	210	$	59	$	167

As of December 31, 2021, we had committed to make the following minimum payments under our non-cancellable operating leases:


	2022		2023		2024		2025		2026		Thereafter		Total
Lease payments	$	84	$	72	$	60	$	50	$	45	$	214	$	525
Imputed lease interest													(60)
Total lease liabilities													$	465

The weighted-average remaining lease term was 9.2 years and 8.9 years as of December 31, 2021 and 2020, respectively. The weighted-average discount rate was 2.51% and 3.02% as of December 31, 2021 and 2020, respectively.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and contingencies

Purchase commitments

Our purchase commitments include payments for software licenses and contractual arrangements with suppliers when there is a fixed, non-cancellable payment schedule or when minimum payments are due with a reduced delivery schedule.

As of December 31, 2021, we had committed to make the following minimum payments under our purchase commitments:


	2022		2023		2024		2025		2026		Thereafter		Total
Purchase commitments	$	564	$	436	$	433	$	43	$	26	$	74	$	1,576

Indemnification guarantees

We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.

Warranty costs/product liabilities

We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.

General

We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.

Supplemental financial information

12 Months Ended

Dec. 31, 2021

Disclosure Text Block Supplement [Abstract]

Supplemental financial information

Restructuring charges/other

Restructuring charges/other are included in Other for segment reporting purposes and are comprised of the following components:


	For Years Ended December 31,
	2021		2020		2019
Restructuring charges (a)	$	—	$	25	$	(15)
Integration charges (b)	104		—		—
Gains on sales of assets (c)	(50)		(1)		(21)
Restructuring charges/other	$	54	$	24	$	(36)

(a)Includes severance and benefits, accelerated depreciation, changes in estimates and other exit costs.

(b)Includes costs related to our purchase of the Lehi, Utah, manufacturing facility, as well as ongoing costs until production begins in early 2023.

(c)Includes a $50 million gain from the sale of property in October 2021.

Changes in accrued restructuring balances


	2021		2020		2019
Balance, January 1	$	18	$	—	$	28
Restructuring charges	—		25		(15)
Non-cash items (a)	—		1		—
Payments	(13)		(8)		(13)
Balance, December 31	$	5	$	18	$	—

(a)Reflects charges for impacts of changes in exchange rates and accelerated depreciation.

The restructuring accrual balances are reported as a component of either accrued expenses and other liabilities or other long-term liabilities on our Consolidated Balance Sheets, depending on the expected timing of payment.

In 2020, we recognized $25 million of restructuring charges primarily for severance and benefit costs associated with our Embedded Processing business. As of December 31, 2021, $21 million of payments have been made.

In 2020, we announced a multiyear plan to close our two remaining factories with 150-millimeter production, located in Sherman and Dallas, Texas. During 2021 we decided not to close a portion of our factory in Dallas. We expect this plan to be completed no later than 2025. Charges for the closures cannot be reasonably estimated at this time.

Other income (expense), net (OI&E)


	For Years Ended December 31,
	2021		2020		2019
Other income (a)	$	145	$	327	$	201
Other expense (b)	(2)		(14)		(26)
Total	$	143	$	313	$	175

(a)Other income includes royalty and lease income, investment gains and losses, interest income, as well as reversals of tax interest accruals.

(b)Other expense includes a portion of pension and other retiree benefit costs, currency gains and losses and miscellaneous items.

Property, plant and equipment at cost


	Depreciable Lives (Years)	December 31,
		2021		2020
Land	n/a	$	132	$	125
Buildings and improvements	5 – 40	3,490		2,571
Machinery and equipment	2 – 10	4,236		3,085
Total		$	7,858	$	5,781

In October 2021, we completed our purchase of a 300-millimeter semiconductor factory in Lehi, Utah, for cash consideration of $893 million. The estimated fair value of assets acquired was determined based on market comparable information to purchase or build comparable assets and allocated on a relative basis to purchase consideration. Assets acquired included $28 million of land, $305 million of buildings and improvements and $526 million of machinery and equipment.

Goodwill

Goodwill by segment as of December 31, 2021 and 2020, is as follows:


	Goodwill
Analog	$	4,158
Embedded Processing	172
Other	32
Total	$	4,362

We perform our annual goodwill impairment test in the fourth quarter and determine whether the fair value of each of our reporting units is in excess of its carrying value. In 2021, we elected to perform a qualitative analysis to assess impairment of goodwill rather than to perform the quantitative goodwill impairment test. The key qualitative factors considered in the assessment included the change in the industry and competitive environment, market capitalization and overall financial performance. Based on this qualitative analysis, we determined that it was more likely than not that the fair value of each reporting unit exceeded its carrying value. In 2021, 2020 and 2019, we determined no impairment was indicated.

Other long-term liabilities


	December 31,
	2021		2020
Long-term portion of transition tax on indefinitely reinvested earnings	$	403	$	457
Deferred compensation plans	395		350
Operating lease liabilities	383		249
Other	186		249
Total	$	1,367	$	1,305

Accumulated other comprehensive income (loss), net of taxes (AOCI)


	December 31,
	2021		2020
Postretirement benefit plans:
Net actuarial loss	$	(155)	$	(359)
Prior service credit	—		1
Cash flow hedge derivative instruments	(2)		(2)
Total	$	(157)	$	(360)

Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income

Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income in 2021, 2020 and 2019. The table below details where these transactions are recorded in our Consolidated Statements of Income.


	For Years Ended December 31,						Impact to Related Statement of Income Lines
	2021		2020		2019
Net actuarial losses of defined benefit plans:
Recognized net actuarial loss and settlement losses (a)	$	37	$	38	$	51	Decrease to OI&E
Tax effect	(8)		(9)		(13)		Decrease to provision for income taxes
Recognized within net income, net of taxes	$	29	$	29	$	38	Decrease to net income

Prior service credit of defined benefit plans:
Amortization of prior service credit (a)	$	(1)	$	(1)	$	—	Increase to OI&E
Tax effect	—		—		—		Increase to provision for income taxes
Recognized within net income, net of taxes	$	(1)	$	(1)	$	—	Increase to net income

(a)Detailed in Note 7.

Basis of Presentation and Significant Accounting Policies and Practices (Policies)	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The basis of these financial statements is comparable for all periods presented herein. The consolidated financial statements include the accounts of all subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All dollar and share amounts in the financial statements and tables in these notes, except per-share amounts, are presented in millions unless otherwise indicated. We have reclassified certain amounts in the prior periods’ financial statements to conform to the 2021 presentation. The preparation of financial statements requires the use of estimates from which final results may vary.
Revenue recognition	Revenue recognition We generate revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, and recognize revenue when control is transferred. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where required, when the customer has accepted the products. This transfer generally occurs at a point in time upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Payment for sales to customers and distributors is generally due on our standard commercial terms. For sales to distributors, payment is not contingent upon resale of the products. Revenue from sales of our products that are subject to inventory consignment agreements is recognized at a point in time, when the customer or distributor pulls product from consignment inventory that we store at designated locations. Delivery and transfer of control occur at that point, when title and risk of loss transfers and the customer or distributor becomes obligated to pay for the products pulled from inventory. Until the products are pulled for use or sale by the customer or distributor, we retain control over the products’ disposition, including the right to pull back or relocate the products. The revenue recognized is adjusted based on allowances, which are prepared on a portfolio basis using a most likely amount methodology based on analysis of historical data and contractual terms. These allowances, which are not material, generally include adjustments for pricing arrangements, product returns, incentives and credit losses. We recognize shipping fees, if any, received from customers in revenue. We include the related shipping and handling costs in cost of revenue. The majority of our customers pay these fees directly to third parties.
Advertising costs	Advertising costsWe expense advertising and other promotional costs as incurred.
Income taxes	Income taxes We account for income taxes using an asset and liability approach. We record the amount of taxes payable or refundable for the current year and the deferred tax assets and liabilities for future tax consequences related to events that have been recognized in the financial statements or tax returns. We record a valuation allowance when it is more likely than not that some or all of the deferred tax assets will not be realized.
Other assessed taxes	Other assessed taxes Some transactions require us to collect taxes such as sales, value-added and excise taxes from our customers. These transactions are presented in our Consolidated Statements of Income on a net (excluded from revenue) basis.
Leases	Leases We determine if an arrangement is a lease at inception. Leases are included in other long-term assets, accrued expenses and other liabilities, and other long-term liabilities on our Consolidated Balance Sheets. Lease assets represent our right to use underlying assets for the lease term, and lease liabilities represent our obligations to make lease payments over the lease term. On the commencement date, leases are evaluated for classification, and assets and liabilities are recognized based on the present value of lease payments over the lease term. We use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. Operating lease expense is generally recognized on a straight-line basis over the lease term. Our lease values include options to extend or not to terminate the lease when it is reasonably certain that we will exercise such options. We have agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with an initial lease term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.
Earnings per share (EPS)	Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.
Investments	Investments We present investments on our Consolidated Balance Sheets as cash equivalents, short-term investments or other long-term assets. See Note 6 for additional information. •Cash equivalents and short-term investments – The primary objectives of our cash equivalent and short-term investment activities are to preserve capital and maintain liquidity while generating appropriate returns. We consider investments in available-for-sale debt securities with maturities of 90 days or less from the date of our investment to be cash equivalents. We consider investments in available-for-sale debt securities with maturities beyond 90 days from the date of our investment as being available for use in current operations and include them in short-term investments. •Other long-term assets – Long-term investments, which are included within other long-term assets on our Consolidated Balance Sheets, consist of mutual funds, venture capital funds and non-marketable equity securities. Investments measured at fair value Money market funds, available-for-sale debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E.
Inventories	Inventories Inventories are stated at the lower of cost or estimated net realizable value. Cost is generally computed on a currently adjusted standard cost basis, which approximates cost on a first-in, first-out basis. Standard cost is based on the normal utilization of installed factory capacity. Cost associated with underutilization of capacity is expensed as incurred. Inventory held at consignment locations is included in our finished goods inventory. We review inventory quarterly for salability and obsolescence. A statistical allowance is provided for inventory considered unlikely to be sold. The statistical allowance is based on an analysis of historical disposal activity, historical customer shipments, as well as estimated future sales. A specific allowance for each material type will be carried if there is a significant event not captured by the statistical allowance. We write off inventory in the period in which disposal occurs.
Property, plant and equipment; acquisition-related intangibles and other capitalized costs	Property, plant and equipment; acquisition-related intangibles; and other capitalized costs Property, plant and equipment are stated at cost and depreciated over their estimated useful lives using the straight-line method. Our cost basis includes certain assets acquired in business combinations that were initially recorded at fair value as of the date of acquisition. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements. We amortize acquisition-related intangibles on a straight-line basis over the estimated economic life of the assets. Capitalized software licenses generally are amortized on a straight-line basis over the term of the license. Fully depreciated or amortized assets are written off against accumulated depreciation or amortization.
Impairments of long-lived assets	Impairments of long-lived assets We regularly review whether facts or circumstances exist that indicate the carrying values of property, plant and equipment or other long-lived assets, including intangible assets, are impaired. We assess the recoverability of assets by comparing the projected undiscounted net cash flows associated with those assets to their respective carrying amounts. Any impairment charge is based on the excess of the carrying amount over the fair value of those assets. Fair value is determined by available market valuations, if applicable, or by discounted cash flows.
Goodwill	Goodwill Goodwill is reviewed for impairment annually in the fourth quarter or more frequently if certain impairment indicators arise. We perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If, as a result of the qualitative assessment, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then we perform the quantitative goodwill impairment test. See Note 11 for additional information.
Foreign currency	Foreign currency The functional currency for our non-U.S. subsidiaries is the U.S. dollar. Accounts recorded in currencies other than the U.S. dollar are remeasured into the functional currency. Current assets (except inventories), deferred taxes, other long-term assets, current liabilities and long-term liabilities are remeasured at exchange rates in effect at the end of each reporting period. Property, plant and equipment with associated depreciation and inventories are valued at historical exchange rates. Revenue and expense accounts other than depreciation for each month are calculated at the appropriate daily rate of exchange. Currency exchange gains and losses from remeasurement are credited or charged to OI&E.
Derivatives and hedging	Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions were not material. We do not use derivatives for speculative or trading purposes.
Stock compensation	We recognize compensation expense for non-qualified stock options and RSUs on a straight-line basis over the minimum service period required for vesting of the award, adjusting for estimated forfeitures based on historical activity. Awards issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis. Options issued under our ESPP are expensed over a three-month period. As of December 31, 2021, total future compensation related to equity awards not yet recognized in our Consolidated Statements of Income was $271 million, which we expect to recognize over a weighted average period of 1.7 years. We use market-based measures of implied volatility to determine expected volatility on all options granted. We determine expected lives of options based on the historical option exercise experience of our option holders using a rolling 10-year average. Expected dividend yields are based on the annualized approved quarterly dividend rate and the current market price of our common stock at the time of grant. No assumption for a future dividend rate change is included unless there is an approved plan to change the dividend in the near term.
Fair values considerations	Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements. •Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date. •Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets. •Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of December 31, 2021 and 2020, we had no Level 3 assets or liabilities.
Indemnification guarantees and warranty costs/product liabilities	Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.

Description of Business, Including Segment and Geographic Area Information (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Schedule of Revenue and Operating Profit, by Segment

Segment information


	For Years Ended December 31,
	2021		2020		2019
Revenue:
Analog	$	14,050	$	10,886	$	10,223
Embedded Processing	3,049		2,570		2,943
Other	1,245		1,005		1,217
Total revenue	$	18,344	$	14,461	$	14,383

Operating profit:
Analog	$	7,393	$	4,912	$	4,477
Embedded Processing	1,174		743		907
Other	393		239		339
Total operating profit	$	8,960	$	5,894	$	5,723

Schedule of Revenue, by Geographic Area

Geographic area information


	For Years Ended December 31,
	2021		2020		2019
Revenue:
United States	$	1,906	$	1,547	$	1,827
Asia (a)	12,185		9,541		8,650
Europe, Middle East and Africa	2,802		2,249		2,707
Japan	959		734		796
Rest of world	492		390		403
Total revenue	$	18,344	$	14,461	$	14,383

Schedule Property, Plant and Equipment by Geographic Area


	December 31,
	2021		2020
Property, plant and equipment:
United States	$	3,648	$	2,036
Asia (a)	1,292		1,005
Europe, Middle East and Africa	47		52
Japan	139		165
Rest of world	15		11
Total property, plant and equipment	$	5,141	$	3,269

Basis of Presentation and Significant Accounting Policies and Practices (Tables)

12 Months Ended

Dec. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Earnings per Share, Basic and Diluted

Computation and reconciliation of earnings per common share are as follows:


	For Years Ended December 31,
	2021					2020					2019
	Net Income		Shares	EPS		Net Income		Shares	EPS		Net Income		Shares	EPS
Basic EPS:
Net income	$	7,769				$	5,595				$	5,017
Income allocated to RSUs	(33)					(27)					(32)
Income allocated to common stock	$	7,736	923	$	8.38	$	5,568	921	$	6.05	$	4,985	936	$	5.33
Dilutive effect of stock compensation plans			13					12					16

Diluted EPS:
Net income	$	7,769				$	5,595				$	5,017
Income allocated to RSUs	(33)					(27)					(31)
Income allocated to common stock	$	7,736	936	$	8.26	$	5,568	933	$	5.97	$	4,986	952	$	5.24

Stock Compensation (Tables)

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Stock Compensation Expense Allocation Within the Consolidated Statements of Income

Total stock compensation expense recognized is as follows:


	For Years Ended December 31,
	2021		2020		2019
COR	$	21	$	21	$	21
R&D	67		68		66
SG&A	134		135		130
Restructuring charges/other	8		—		—
Total	230		224		217

Schedule of Weighted Average Assumptions Used to Estimate the Fair Values for Non-qualified Stock Options

We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions:


	For Years Ended December 31,
	2021			2020			2019
Weighted average grant date fair value, per share	$	40.78		$	25.55		$	22.08
Weighted average assumptions used:
Expected volatility	32		%	26		%	26		%
Expected lives (in years)	6.7			6.8			7.1
Risk-free interest rates	0.72		%	1.53		%	2.66		%
Expected dividend yields	2.41		%	2.76		%	2.95		%

Schedule of Stock Option and RSU Transactions Under Long-term Incentive and Director Compensation Plans

Stock option and RSU transactions under our long-term incentive and director compensation plans are as follows:


	Stock Options			RSUs
	Shares	Weighted Average Exercise Price per Share		Shares	Weighted Average Grant Date Fair Value per Share
Outstanding grants, December 31, 2020	28	$	79.69	5	$	100.80
Granted	3	169.52		1	176.08
Stock options exercised/RSUs vested	(6)	65.89		(2)	81.31
Outstanding grants, December 31, 2021 (a)	25	91.58		4	124.80

(a) Forfeited and expired shares were not material.


	For Years Ended December 31,
	2021		2020		2019
Weighted average grant date fair value per share for RSUs	$	176.08	$	130.59	$	106.58
Total grant date fair value of shares vested for RSUs	$	115	$	110	$	125
Aggregate intrinsic value of options exercised	$	611	$	681	$	819

Schedule of Shares Outstanding Under Stock Option Plans, by Exercise Price Range

Summarized information about stock options outstanding as of December 31, 2021, is as follows:


		Stock Options Outstanding
Exercise Price Range		Number Outstanding (Shares)	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price per Share
$	28.13 to 193.58	25	5.5	$	91.58

Schedule of Stock Options That are Vested and Expected to Vest, Outstanding and Exercisable


	Options Fully Vested and Expected to Vest (a)		Options Exercisable
Options outstanding (shares)	25		16
Weighted average remaining contractual life (in years)	5.5		4.2
Weighted average exercise price per share	$	90.97	$	69.43
Intrinsic value	$	2,408	$	1,952

(a)Includes effects of expected forfeitures. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $2.42 billion.

Schedule of Changes in Treasury Stock

The following table reflects the changes in our treasury shares:


	For Years Ended December 31,
	2021	2020	2019
Balance, January 1	821	809	796
Repurchases	3	23	27
Shares issued	(7)	(11)	(14)
Balance, December 31	817	821	809

Schedule of Cash Proceeds Received from Share-based Payment Awards

The effects on cash flows are as follows:


	For Years Ended December 31,
	2021		2020		2019
Proceeds from common stock transactions (a)	$	377	$	470	$	539

Tax benefit realized from stock compensation	$	175	$	195	$	224
Reduction to deferred tax asset	(39)		(44)		(49)
Excess tax benefit for stock compensation	$	136	$	151	$	175

(a)Net of taxes paid for employee shares withheld of $53 million, $53 million and $52 million in 2021, 2020 and 2019, respectively.

Income taxes (Tables)

12 Months Ended

Dec. 31, 2021

Income Tax Disclosure [Abstract]

Income before income taxes

Income before income taxes is comprised of the following components:


	For Years Ended December 31,
	2021		2020		2019
U.S.	$	7,998	$	5,210	$	4,915
Non-U.S.	921		807		813
Total	$	8,919	$	6,017	$	5,728

Provision for income taxes

Provision for income taxes is comprised of the following components:


	For Years Ended December 31,
	2021						2020						2019
	Current		Deferred		Total		Current		Deferred		Total		Current		Deferred		Total
U.S. federal	$	948	$	(23)	$	925	$	357	$	(122)	$	235	$	483	$	25	$	508
Non-U.S.	169		38		207		192		(15)		177		135		56		191
U.S. state	18		—		18		10		—		10		12		—		12
Total	$	1,135	$	15	$	1,150	$	559	$	(137)	$	422	$	630	$	81	$	711

Principal reconciliation items from U.S. statutory income tax rate to the effective tax rate

Principal reconciling items from the U.S. statutory income tax rate to the effective tax rate (provision for income taxes as a percentage of income before income taxes) are as follows:


	For Years Ended December 31,
	2021		2020		2019
U.S. statutory income tax rate	21.0	%	21.0	%	21.0	%
U.S. tax benefit for foreign derived intangible income	(6.1)		(6.1)		(4.9)
U.S. excess tax benefit for stock compensation	(1.5)		(2.5)		(3.1)
U.S. R&D tax credit	(0.9)		(1.3)		(1.4)
Impact of changes in uncertain tax positions	(0.2)		(4.0)		(0.1)
Other	0.6		(0.1)		0.9
Effective tax rate	12.9	%	7.0	%	12.4	%

Primary components of deferred tax assets and liabilities

The primary components of deferred tax assets and liabilities are as follows:


	December 31,
	2021		2020
Deferred tax assets:
Accrued expenses	$	209	$	180
Deferred loss and tax credit carryforwards	207		207
Stock compensation	110		106
Inventories and related reserves	74		105
Retirement costs for defined benefit and retiree health care	—		44
Other	40		3
Total deferred tax assets, before valuation allowance	640		645
Valuation allowance	(188)		(179)
Total deferred tax assets, after valuation allowance	452		466
Deferred tax liabilities:
Property, plant and equipment	(197)		(116)
International earnings	(38)		(44)
Retirement costs for defined benefit and retiree health care	(15)		—
Acquisition-related intangibles and fair-value adjustments	(12)		(40)
Other	(14)		(13)
Total deferred tax liabilities	(276)		(213)
Net deferred tax asset	$	176	$	253

Deferred tax assets and liabilities presentation on the Balance sheet

The deferred tax assets and liabilities based on tax jurisdictions are presented on our Consolidated Balance Sheets as follows:


	December 31,
	2021		2020
Deferred tax assets	$	263	$	343
Deferred tax liabilities	(87)		(90)
Net deferred tax asset	$	176	$	253

Summary of uncertain tax positions

The changes in the total amounts of uncertain tax positions are as follows:


	2021		2020		2019
Balance, January 1	$	89	$	303	$	286
Additions based on tax positions related to the current year	2		3		3
Additions for tax positions of prior years	7		35		63
Reductions for tax positions of prior years	(6)		(249)		(41)
Settlements with tax authorities	(23)		—		(8)
Expiration of the statute of limitations for assessing taxes	—		(3)		—
Balance, December 31	$	69	$	89	$	303

Interest income (expense) recognized in the year ended December 31	$	(5)	$	39	$	9

Interest payable as of December 31	$	13	$	8	$	44

Valuation of Debt and Equity Investments and Certain Liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Investments

Details of our investments are as follows:


	December 31, 2021						December 31, 2020
	Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments		Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments
Measured at fair value:
Money market funds	$	1,824	$	—	$	—	$	886	$	—	$	—
Corporate obligations	1,060		1,070		—		256		257		—
U.S. government and agency securities	642		3,388		—		1,340		3,054		—
Non-U.S. government and agency securities	300		650		—		—		150		—
Mutual funds	—		—		16		—		—		18
Total	3,826		5,108		16		2,482		3,461		18

Other measurement basis:
Equity-method investments	—		—		42		—		—		27
Non-marketable equity investments	—		—		4		—		—		4
Cash on hand	805		—		—		625		—		—
Total	$	4,631	$	5,108	$	62	$	3,107	$	3,461	$	49

Assets and Liabilities Accounted for at Fair Value


	December 31, 2021						December 31, 2020
	Level 1		Level 2		Total		Level 1		Level 2		Total
Assets:
Money market funds	$	1,824	$	—	$	1,824	$	886	$	—	$	886
Corporate obligations	—		2,130		2,130		—		513		513
U.S. government and agency securities	3,629		401		4,030		4,394		—		4,394
Non-U.S. government and agency securities	—		950		950		—		150		150
Mutual funds	16		—		16		18		—		18
Total assets	$	5,469	$	3,481	$	8,950	$	5,298	$	663	$	5,961

Liabilities:
Deferred compensation	$	395	$	—	$	395	$	350	$	—	$	350
Total liabilities	$	395	$	—	$	395	$	350	$	—	$	350

Postretirement Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2021

Retirement Benefits [Abstract]

Expenses related to defined benefit and retiree health care benefit plans are as follows:


	U.S. Defined Benefit						U.S. Retiree Health Care						Non-U.S. Defined Benefit
	2021		2020		2019		2021		2020		2019		2021		2020		2019
Service cost	$	21	$	18	$	18	$	3	$	3	$	3	$	36	$	34	$	31
Interest cost	30		31		38		10		13		14		37		38		43
Expected return on plan assets	(31)		(36)		(41)		(9)		(12)		(14)		(81)		(78)		(86)
Amortization of prior service cost (credit)	—		—		—		(2)		(2)		(1)		1		1		1
Recognized net actuarial loss	15		7		9		—		—		—		7		14		29
Net periodic benefit costs	35		20		24		2		2		2		—		9		18
Settlement losses	13		16		10		—		—		—		2		1		3
Total, including other postretirement losses	$	48	$	36	$	34	$	2	$	2	$	2	$	2	$	10	$	21

Schedule of Changes in the Benefit Obligations and Plan Assets for the Defined Benefit and Retiree Health Care Benefit Plans

Changes in the benefit obligations and plan assets for defined benefit and retiree health care benefit plans are as follows:


	U.S. Defined Benefit				U.S. Retiree Health Care				Non-U.S. Defined Benefit
	2021		2020		2021		2020		2021		2020
Change in plan benefit obligation
Benefit obligation at beginning of year:	$	1,097	$	960	$	389	$	359	$	2,868	$	2,581
Service cost	21		18		3		3		36		34
Interest cost	30		31		10		13		37		38
Participant contributions	—		—		14		13		9		7
Benefits paid	(12)		(12)		(38)		(39)		(101)		(95)
Settlements	(162)		(94)		—		—		(12)		(8)

Actuarial loss (gain)	(79)		194		(18)		40		(111)		143
Plan amendments	—		—		—		—		—		1
Effects of exchange rate changes	—		—		—		—		(152)		167
Benefit obligation at end of year	$	895	$	1,097	$	360	$	389	$	2,574	$	2,868

Change in plan assets
Fair value of plan assets at beginning of year:	$	1,061	$	987	$	389	$	356	$	3,008	$	2,661
Actual return on plan assets	37		164		19		58		75		260
Employer contributions (qualified plans)	—		—		1		1		7		11
Employer contributions (non-qualified plans)	10		16		—		—		—		—
Participant contributions	—		—		14		13		9		7
Benefits paid	(12)		(12)		(38)		(39)		(101)		(95)
Settlements	(162)		(94)		—		—		(12)		(8)
Effects of exchange rate changes	—		—		—		—		(173)		172

Fair value of plan assets at end of year	$	934	$	1,061	$	385	$	389	$	2,813	$	3,008

Funded status at end of year	$	39	$	(36)	$	25	$	—	$	239	$	140

Schedule of Amounts Recognized in our Balance Sheet

Amounts recognized on our Consolidated Balance Sheets as of December 31, are as follows:


	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit		Total
2021
Overfunded retirement plans	$	73	$	28	$	291	$	392
Accrued expenses and other liabilities & other long-term liabilities	(5)		—		(5)		(10)
Underfunded retirement plans	(29)		(3)		(47)		(79)
Funded status at end of 2021	$	39	$	25	$	239	$	303

2020
Overfunded retirement plans	$	9	$	3	$	234	$	246
Accrued expenses and other liabilities & other long-term liabilities	(6)		—		(5)		(11)
Underfunded retirement plans	(39)		(3)		(89)		(131)
Funded status at end of 2020	$	(36)	$	—	$	140	$	104

Schedule of Change in AOCI

The change in AOCI is as follows:


	U.S. Defined Benefit		U.S. Retiree Health Care				Non-U.S. Defined Benefit				Total
	Net Actuarial Loss		Net Actuarial Loss		Prior Service Credit		Net Actuarial Loss		Prior Service Credit		Net Actuarial Loss		Prior Service Credit
AOCI balance, net of taxes, December 31, 2020	$	125	$	(8)	$	(2)	$	242	$	1	$	359	$	(1)
Changes in AOCI by category:
Adjustments	(84)		(28)		—		(119)		—		(231)		—
Recognized within net income	(28)		—		2		(9)		(1)		(37)		1
Tax effect	23		6		(1)		35		1		64		—
Total change to AOCI	(89)		(22)		1		(93)		—		(204)		1
AOCI balance, net of taxes, December 31, 2021	$	36	$	(30)	$	(1)	$	149	$	1	$	155	$	—

Schedule of Allocation of Plan Assets

The tables below set forth the fair value of our plan assets using the same three-level hierarchy of fair-value inputs described in Note 6.


	December 31, 2021
	Level 1		Level 2		Other (a)		Total
Assets of U.S. defined benefit plan:
Fixed income securities and cash equivalents	$	—	$	—	$	655	$	655
Equity securities	—		—		279		279
Total	$	—	$	—	$	934	$	934

Assets of U.S. retiree health care plan:
Fixed income securities and cash equivalents	$	10	$	—	$	238	$	248
Equity securities	—		—		137		137
Total	$	10	$	—	$	375	$	385

Assets of non-U.S. defined benefit plans:
Fixed income securities and cash equivalents	$	71	$	104	$	2,045	$	2,220
Equity securities	49		2		542		593
Total	$	120	$	106	$	2,587	$	2,813

(a)Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents.


	December 31, 2020
	Level 1		Level 2		Other (a)		Total
Assets of U.S. defined benefit plan:
Fixed income securities and cash equivalents	$	—	$	—	$	743	$	743
Equity securities	—		—		318		318
Total	$	—	$	—	$	1,061	$	1,061

Assets of U.S. retiree health care plan:
Fixed income securities and cash equivalents	$	29	$	—	$	222	$	251
Equity securities	—		—		138		138
Total	$	29	$	—	$	360	$	389

Assets of non-U.S. defined benefit plans:
Fixed income securities and cash equivalents	$	69	$	146	$	2,063	$	2,278
Equity securities	43		2		685		730
Total	$	112	$	148	$	2,748	$	3,008

(a)Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents.

The target allocation ranges for the plans that hold a substantial majority of the defined benefit assets are as follows:

U.S. Defined Benefit

U.S. Retiree Health Care

Non-U.S. Defined Benefit

Fixed income securities and cash equivalents

65% – 80%

60% – 100%

Equity securities

20% – 35%

0% – 40%

Weighted average asset allocations as of December 31 are as follows:


	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit
	2021	2020	2021	2020	2021	2020
Fixed income securities and cash equivalents	70%	70%	64%	65%	79%	76%
Equity securities	30%	30%	36%	35%	21%	24%

Schedule of Assumptions Used

Assumptions and investment policies


	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit
	2021	2020	2021	2020	2021	2020
Weighted average assumptions used to determine benefit obligations:
Discount rate	2.74%	2.81%	3.05%	2.74%	1.57%	1.31%
Long-term pay progression	3.70%	3.70%	n/a	n/a	3.15%	3.15%

Weighted average assumptions used to determine net periodic benefit cost:
Discount rate	2.95%	3.42%	2.74%	3.63%	1.31%	1.46%
Long-term rate of return on plan assets	3.50%	4.00%	3.10%	3.50%	2.82%	2.93%
Long-term pay progression	3.70%	3.30%	n/a	n/a	3.15%	3.06%

Schedule of Assumed Future Benefit Payments


	2022		2023		2024		2025		2026		2027 – 2031
U.S. Defined Benefit	$	89	$	96	$	87	$	87	$	87	$	391
U.S. Retiree Health Care	28		27		26		25		24		108
Non-U.S. Defined Benefit	99		101		103		105		107		566

Schedule of Assumed Health Care Cost Trend Rates for U.S Retiree Health Care Benefit Plan

Assumed health care cost trend rates for the U.S. retiree health care benefit plan as of December 31 are as follows:


	2021	2020
Assumed health care cost trend rate for next year	6.50%	6.75%
Ultimate trend rate	5.00%	5.00%
Year in which ultimate trend rate is reached	2028	2028

Debt and Lines of Credit (Tables)

12 Months Ended

Dec. 31, 2021

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments

Long-term debt outstanding is as follows:


	December 31,
	2021		2020
Notes due 2021 at 2.75%	$	—	$	550
Notes due 2022 at 1.85%	500		500
Notes due 2023 at 2.25%	500		500
Notes due 2024 at 2.625%	300		300
Notes due 2025 at 1.375%	750		750
Notes due 2026 at 1.125%	500		—
Notes due 2027 at 2.90%	500		500
Notes due 2029 at 2.25%	750		750
Notes due 2030 at 1.75%	750		750
Notes due 2031 at 1.90%	500		—
Notes due 2039 at 3.875%	750		750
Notes due 2048 at 4.15%	1,500		1,500
Notes due 2051 at 2.70%	500		—
Total debt	7,800		6,850
Net unamortized discounts, premiums and issuance costs	(59)		(52)
Total debt, including net unamortized discounts, premiums and issuance costs	7,741		6,798
Current portion of long-term debt	(500)		(550)
Long-term debt	$	7,241	$	6,248

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

+ Details

Leases (Tables)

12 Months Ended

Dec. 31, 2021

Leases [Abstract]

Balance sheet components of leases

Our leases are included as a component of the following balance sheet lines:


	December 31,
	2021		2020
Other long-term assets	$	465	$	319

Accrued expenses and other liabilities	$	82	$	72
Other long-term liabilities	383		249

Schedule of Operating Leases

Details of our operating leases are as follows:


	For Years Ended December 31,
	2021		2020		2019
Lease cost related to lease liabilities	$	69	$	70	$	66
Variable lease cost	56		36		41

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for lease cost	$	61	$	59	$	60

Lease assets obtained in exchange for new lease liabilities	$	210	$	59	$	167

Maturities of operating leases

As of December 31, 2021, we had committed to make the following minimum payments under our non-cancellable operating leases:


	2022		2023		2024		2025		2026		Thereafter		Total
Lease payments	$	84	$	72	$	60	$	50	$	45	$	214	$	525
Imputed lease interest													(60)
Total lease liabilities													$	465

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Minimum Payments Under Purchase Commitments

As of December 31, 2021, we had committed to make the following minimum payments under our purchase commitments:


	2022		2023		2024		2025		2026		Thereafter		Total
Purchase commitments	$	564	$	436	$	433	$	43	$	26	$	74	$	1,576

Supplemental financial information (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure Text Block Supplement [Abstract]

Restructuring charges and other

Restructuring charges/other are included in Other for segment reporting purposes and are comprised of the following components:


	For Years Ended December 31,
	2021		2020		2019
Restructuring charges (a)	$	—	$	25	$	(15)
Integration charges (b)	104		—		—
Gains on sales of assets (c)	(50)		(1)		(21)
Restructuring charges/other	$	54	$	24	$	(36)

(a)Includes severance and benefits, accelerated depreciation, changes in estimates and other exit costs.

(b)Includes costs related to our purchase of the Lehi, Utah, manufacturing facility, as well as ongoing costs until production begins in early 2023.

(c)Includes a $50 million gain from the sale of property in October 2021.

Changes in accrued restructuring balances


	2021		2020		2019
Balance, January 1	$	18	$	—	$	28
Restructuring charges	—		25		(15)
Non-cash items (a)	—		1		—
Payments	(13)		(8)		(13)
Balance, December 31	$	5	$	18	$	—

(a)Reflects charges for impacts of changes in exchange rates and accelerated depreciation.

Other income (expense), net (OI&E)


	For Years Ended December 31,
	2021		2020		2019
Other income (a)	$	145	$	327	$	201
Other expense (b)	(2)		(14)		(26)
Total	$	143	$	313	$	175

(a)Other income includes royalty and lease income, investment gains and losses, interest income, as well as reversals of tax interest accruals.

(b)Other expense includes a portion of pension and other retiree benefit costs, currency gains and losses and miscellaneous items.

Property, plant and equipment at cost


	Depreciable Lives (Years)	December 31,
		2021		2020
Land	n/a	$	132	$	125
Buildings and improvements	5 – 40	3,490		2,571
Machinery and equipment	2 – 10	4,236		3,085
Total		$	7,858	$	5,781

Schedule of goodwill

Goodwill by segment as of December 31, 2021 and 2020, is as follows:


	Goodwill
Analog	$	4,158
Embedded Processing	172
Other	32
Total	$	4,362

Other long-term liabilities


	December 31,
	2021		2020
Long-term portion of transition tax on indefinitely reinvested earnings	$	403	$	457
Deferred compensation plans	395		350
Operating lease liabilities	383		249
Other	186		249
Total	$	1,367	$	1,305

Accumulated other comprehensive income (loss), net of taxes (AOCI)


	December 31,
	2021		2020
Postretirement benefit plans:
Net actuarial loss	$	(155)	$	(359)
Prior service credit	—		1
Cash flow hedge derivative instruments	(2)		(2)
Total	$	(157)	$	(360)

Amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income

The table below details where these transactions are recorded in our Consolidated Statements of Income.


	For Years Ended December 31,						Impact to Related Statement of Income Lines
	2021		2020		2019
Net actuarial losses of defined benefit plans:
Recognized net actuarial loss and settlement losses (a)	$	37	$	38	$	51	Decrease to OI&E
Tax effect	(8)		(9)		(13)		Decrease to provision for income taxes
Recognized within net income, net of taxes	$	29	$	29	$	38	Decrease to net income

Prior service credit of defined benefit plans:
Amortization of prior service credit (a)	$	(1)	$	(1)	$	—	Increase to OI&E
Tax effect	—		—		—		Increase to provision for income taxes
Recognized within net income, net of taxes	$	(1)	$	(1)	$	—	Increase to net income

(a)Detailed in Note 7.

Description of Business, Including Segment and Geographic Area Information - Additional Information (Details) - reportable_segment	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting [Abstract]
Number of reportable segments	2
Customer Number One \| Revenue Benchmark \| Customer Concentration Risk
Major Customer [Line Items]
Concentration Risk	9.00%	10.00%	8.00%

Description of Business, Including Segment and Geographic Area Information - Schedule of Revenue and Operating Profit by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Total revenue	$ 18,344	$ 14,461	$ 14,383
Total operating profit	8,960	5,894	5,723
Analog
Segment Reporting Information [Line Items]
Total revenue	14,050	10,886	10,223
Total operating profit	7,393	4,912	4,477
Embedded Processing
Segment Reporting Information [Line Items]
Total revenue	3,049	2,570	2,943
Total operating profit	1,174	743	907
Other
Segment Reporting Information [Line Items]
Total revenue	1,245	1,005	1,217
Total operating profit	$ 393	$ 239	$ 339

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Description of Business, Including Segment and Geographic Area Information - Schedule of Revenue by Geographic Area (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Segment Reporting Information [Line Items]

Total revenue

$ 18,344

$ 14,461

$ 14,383

United States

Segment Reporting Information [Line Items]

Total revenue

1,906

1,547

1,827

Asia

Segment Reporting Information [Line Items]

Total revenue

^[1]

12,185

9,541

8,650

Europe, Middle East And Africa

Segment Reporting Information [Line Items]

Total revenue

2,802

2,249

2,707

Japan

Segment Reporting Information [Line Items]

Total revenue

959

734

796

Rest of world

Segment Reporting Information [Line Items]

Total revenue

492

390

403

China

Segment Reporting Information [Line Items]

Total revenue

$ 10,000

$ 8,000

$ 7,200

[1]

Revenue from products shipped into China was $10.0 billion, $8.0 billion and $7.2 billion in 2021, 2020 and 2019, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

- Definition

+ References

+ Details

Description of Business, Including Segment and Geographic Area Information - Schedule of Property, Plant and Equipment by Geographic Area (Details)
$ in Millions

Dec. 31, 2021

USD ($)

site

Dec. 31, 2020

USD ($)

site

Segment Reporting Information [Line Items]

Total property, plant and equipment

$ 5,141

$ 3,269

United States

Segment Reporting Information [Line Items]

Total property, plant and equipment

3,648

2,036

Asia

Segment Reporting Information [Line Items]

Total property, plant and equipment

^[1]

1,292

1,005

Europe, Middle East And Africa

Segment Reporting Information [Line Items]

Total property, plant and equipment

Japan

Segment Reporting Information [Line Items]

Total property, plant and equipment

139

165

Rest of world

Segment Reporting Information [Line Items]

Total property, plant and equipment

Philippines

Segment Reporting Information [Line Items]

Total property, plant and equipment

$ 370

$ 333

Number of sites | site

China

Segment Reporting Information [Line Items]

Total property, plant and equipment

$ 570

$ 370

[1]	Property, plant and equipment at our two sites in the Philippines was $370 million and $333 million as of December 31, 2021 and 2020, respectively. Property, plant and equipment at our sites in China was $570 million and $370 million as of December 31, 2021 and 2020, respectively.

Basis of Presentation and Significant Accounting Policies and Practices - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Advertising expense	$ 27	$ 28	$ 30
Antidilutive securities excluded from computation of earnings per share, Amount (in shares)	3	4	6
Maximum length to maturity of a security, from the investment date, where it is classified as cash and cash equivalent	90 days
Length to maturity from the investment date of a security where the length of time is too short to be classified as a short-term investment	90 days

Basis of Presentation and Significant Accounting Policies and Practices - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Basic EPS:
Net income	$ 7,769	$ 5,595	$ 5,017
Income allocated to RSUs	(33)	(27)	(32)
Income allocated to common stock for basic EPS	$ 7,736	$ 5,568	$ 4,985
Weighted average number of shares outstanding, basic (in shares)	923	921	936
Basic earnings per common share (in dollars per share)	$ 8.38	$ 6.05	$ 5.33
Dilutive effect of stock compensation plans	13	12	16
Diluted EPS:
Net income	$ 7,769	$ 5,595	$ 5,017
Income allocated to RSUs	(33)	(27)	(31)
Income allocated to common stock for diluted EPS	$ 7,736	$ 5,568	$ 4,986
Weighted average number of shares outstanding, diluted (in shares)	936	933	952
Diluted earnings per common share (in dollars per share)	$ 8.26	$ 5.97	$ 5.24

Stock Compensation - Additional Information (Details) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($) shares
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of shares remaining available for future issuance (in shares) \| shares	37
Future compensation not yet recognized in the Statements of Income \| $	$ 271
Weighted average recognition period	1 year 8 months 12 days
Remaining stock repurchase authorizations \| $	$ 10,100
Employee stock purchase plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Percent of the underlying common stock's market price participants pay for options (in hundredths)	85.00%
Number of shares remaining available for future issuance (in shares) \| shares	33
ESPP option term (in months)	3 months
Long-term incentive and director compensation plans \| Employee Stock Option
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Term of the long term incentive stock options	10 years
Award vesting period (in years)	4 years
Long-term incentive and director compensation plans \| Restricted Stock Units (RSUs)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Award vesting period (in years)	4 years

Stock Compensation - Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	$ 230	$ 224	$ 217
COR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	21	21	21
R&D
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	67	68	66
SG&A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	134	135	130
Restructuring charges/other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	$ 8	$ 0	$ 0

Stock Compensation - Fair-value Methods and Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
Weighted average grant date fair value, per share (in dollars per share)	$ 40.78	$ 25.55	$ 22.08
Expected volatility (in percent)	32.00%	26.00%	26.00%
Expected lives	6 years 8 months 12 days	6 years 9 months 18 days	7 years 1 month 6 days
Risk-free interest rates (in percent)	0.72%	1.53%	2.66%
Expected dividend yields (in percent)	2.41%	2.76%	2.95%

Stock Compensation - Stock Options and RSUs Outstanding (Details) - Long-term incentive and director compensation plans - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Employee Stock Option
Stock Options, Shares
Options outstanding, Beginning balance (in shares)	28
Granted (in shares)	3
Exercised (in shares)	(6)
Options outstanding, Ending balance (in shares)	25	28
Stock Options, Weighted Average Exercise Price per Share
Weighted-average exercise price, Outstanding, Beginning of period (in dollars per share)	$ 79.69
Weighted-average exercise price, Granted (in dollars per share)	169.52
Weighted-average exercise price, Exercised (in dollars per share)	65.89
Weighted-average exercise price, Outstanding, End of period (in dollars per share)	$ 91.58	$ 79.69
Restricted Stock Units, Weighted Average Grant Date Fair Value per Share
Aggregate intrinsic values of options exercised	$ 611	$ 681	$ 819
Restricted Stock Units (RSUs)
Restricted Stock Units, Shares
Awards outstanding other than options, Beginning balance (in shares)	5
Granted (in shares)	1
Vested (in shares)	(2)
Awards outstanding other than options, Ending balance (in shares)	4	5
Restricted Stock Units, Weighted Average Grant Date Fair Value per Share
Weighted-average grant date fair value, Beginning of period (in dollars per share)	$ 100.80
Weighted-average grant-date fair value, Granted (in dollars per share)	176.08	$ 130.59	$ 106.58
Weighted-average grant date fair value, Vested (in dollars per share)	81.31
Weighted-average grant date fair value, Ending of period (in dollars per share)	124.80	100.80
Weighted-average grant-date fair value, Granted (in dollars per share)	$ 176.08	$ 130.59	$ 106.58
Total fair values of shares vested from RSU lapses	$ 115	$ 110	$ 125

Stock Compensation - Exercise Price Range (Details) - Employee Stock Option - Long-term incentive and director compensation plans - $ / shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Minimum (in dollars per share)	$ 28.13
Exercise Price Range, Maximum (in dollars per share)	$ 193.58
Number Outstanding (Shares)	25	28
Weighted Average Remaining Contractual Life (Years)	5 years 6 months
Options Outstanding Weighted Average Exercise Price per Share (in dollars per share)	$ 91.58	$ 79.69

Stock Compensation - Options Vested and Expected to Vest (Details) - Long-term incentive and director compensation plans - Employee Stock Option
$ / shares in Units, shares in Millions, $ in Millions

12 Months Ended

Dec. 31, 2021

USD ($)

$ / shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options outstanding, vested and expected to vest (in shares) | shares

^[1]

Weighted average remaining contractual life, vested and expected to vest (in years)

5 years 6 months

^[1]

Weighted average exercise price per share, vested and expected to vest (in dollars per share) | $ / shares

$ 90.97

^[1]

Intrinsic value, vested and expected to vest (millions of dollars)

$ 2,408

^[1]

Outstanding options exercisable (in shares) | shares

Weighted average remaining contractual life, options exercisable

4 years 2 months 12 days

Weighted average exercise price per share, options exercisable (in dollars per share) | $ / shares

$ 69.43

Intrinsic value, options exercisable (millions of dollars)

$ 1,952

Aggregate intrinsic value of stock options outstanding, excluding the effects of expected forfeitures

$ 2,420

[1]	Includes effects of expected forfeitures. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $2.42 billion.

Stock Compensation - Effect on Shares Outstanding and Treasury Shares (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Change In Treasury Stock Roll Forward [Roll Forward]
Treasury stock (in shares)	817	821	809	796
Repurchases (in shares)	3	23	27
Shares issued (in shares)	(7)	(11)	(14)

Stock Compensation - Effects on Cash Flows (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

Proceeds from common stock transactions

^[1]

$ 377

$ 470

$ 539

Tax benefit realized from stock compensation

175

195

224

Reduction to deferred tax asset

(39)

(44)

(49)

Excess tax benefit for stock compensation

136

151

175

Taxes paid for employee shares withheld

$ 53

$ 52

[1]	Net of taxes paid for employee shares withheld of $53 million, $53 million and $52 million in 2021, 2020 and 2019, respectively.

Income taxes - Income before income taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
U.S.	$ 7,998	$ 5,210	$ 4,915
Non-U.S.	921	807	813
Income before income taxes	$ 8,919	$ 6,017	$ 5,728

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

Income taxes - Provision for income taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
U.S. federal - Current	$ 948	$ 357	$ 483
Non-U.S. - Current	169	192	135
U.S. state - Current	18	10	12
Total current income tax expense (benefit)	1,135	559	630
U.S. federal - Deferred	(23)	(122)	25
Non-U.S. - Deferred	38	(15)	56
U.S. state - Deferred	0	0	0
Total deferred income tax expense (benefit)	15	(137)	81
Total U.S. federal income taxes	925	235	508
Total Non-U.S. income taxes	207	177	191
Total U.S. state income taxes	18	10	12
Provision for income taxes	$ 1,150	$ 422	$ 711

Income taxes - Reconciliation items from U.S. statutory income tax rate to the effective tax rate (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
U.S. statutory income tax rate	21.00%	21.00%	21.00%
U.S. tax benefit for foreign derived intangible income	(6.10%)	(6.10%)	(4.90%)
U.S. excess tax benefit for stock compensation	(1.50%)	(2.50%)	(3.10%)
U.S. R&D tax credit	(0.90%)	(1.30%)	(1.40%)
Impact of changes in uncertain tax positions	(0.20%)	(4.00%)	(0.10%)
Other	0.60%	(0.10%)	0.90%
Effective tax rate	12.90%	7.00%	12.40%

Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Change in deferred tax asset valuation allowances	$ 9,000,000	$ (1,000,000)	$ 8,000,000
Net income impacted due to change in valuation allowances	0	0	0
Tax loss carryforward, U.S. and non-U.S.	0
Cash payments for income taxes	1,200,000,000	720,000,000	570,000,000
Liabilities for uncertain tax positions	$ 69,000,000	89,000,000	$ 303,000,000	$ 286,000,000
Amount of deferred tax assets possibly to be realized		2,000,000
Amount of tax benefit for tax settlements		249,000,000
Accrued interest related to uncertain tax position		$ 46,000,000

Income taxes - Components of deferred tax assets and liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Accrued expenses	$ 209	$ 180
Deferred loss and tax credit carryforwards	207	207
Stock compensation	110	106
Inventories and related reserves	74	105
Retirement costs for defined benefit and retiree health care	0	44
Other	40	3
Total deferred tax assets, before valuation allowance	640	645
Valuation allowance	(188)	(179)
Total deferred tax assets, after valuation allowance	452	466
Deferred tax liabilities:
Property, plant and equipment	(197)	(116)
International earnings	(38)	(44)
Retirement costs for defined benefit and retiree health care	(15)	0
Acquisition-related intangibles and fair-value adjustments	(12)	(40)
Other	(14)	(13)
Total deferred tax liabilities	(276)	(213)
Net deferred tax asset	$ 176	$ 253

Income taxes - Deferred tax assets and liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Deferred tax assets	$ 263	$ 343
Deferred tax liabilities	(87)	(90)
Net deferred tax asset	$ 176	$ 253

Income taxes - Uncertain tax positions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance, January 1	$ 89	$ 303	$ 286
Additions based on tax positions related to the current year	2	3	3
Additions for tax positions of prior years	7	35	63
Reductions for tax positions of prior years	(6)	(249)	(41)
Settlements with tax authorities	(23)	0	(8)
Expiration of the statute of limitations for assessing taxes	0	(3)	0
Balance, December 31	69	89	303
Interest income (expense) recognized in the year ended December 31	(5)	39	9
Interest payable as of December 31	$ 13	$ 8	$ 44

Financial Instruments and Risk Concentration - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Valuation and Qualifying Accounts Disclosure [Line Items]
Carrying value of long term debt	$ 7,741	$ 6,798
Allowance for Credit Loss
Valuation and Qualifying Accounts Disclosure [Line Items]
Accounts receivable allowances, amounts charged (credited) to operating results	(3)	$ 3	$ (11)
Level 2
Valuation and Qualifying Accounts Disclosure [Line Items]
Fair value of long term debt	8,380
Foreign Exchange Forward
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	313
Foreign Exchange Forward \| Japanese Yen
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	127
Foreign Exchange Forward \| British Pounds
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	82
Foreign Exchange Forward \| Euros
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	$ 42

Valuation of Debt and Equity Investments and Certain Liabilities - Investments at Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$ 4,631	$ 3,107
Short-term investments	5,108	3,461
Long-term Investments	62	49
Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	3,826	2,482
Short-term investments	5,108	3,461
Long-term Investments	16	18
Measured at fair value \| Available-for-sale debt securities \| Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	1,824	886
Short-term investments	0	0
Long-term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| Corporate obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	1,060	256
Short-term investments	1,070	257
Long-term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| U.S. government and agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	642	1,340
Short-term investments	3,388	3,054
Long-term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| Non-U.S. government and agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	300	0
Short-term investments	650	150
Long-term Investments	0	0
Measured at fair value \| Trading securities \| Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
Short-term investments	0	0
Long-term Investments	16	18
Other measurement basis \| Equity-method investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
Short-term investments	0	0
Long-term Investments	42	27
Other measurement basis \| Non-marketable equity investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
Short-term investments	0	0
Long-term Investments	4	4
Other measurement basis \| Cash on hand
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	805	625
Short-term investments	0	0
Long-term Investments	$ 0	$ 0

Valuation of Debt and Equity Investments and Certain Liabilities - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Credit losses related to available-for-sale investments	$ 0	$ 0	$ 0
Proceeds from sales, redemptions and maturities of short-term available-for-sale securities	8,480,000,000	5,290,000,000	$ 2,310,000,000
Proceeds from sale of short-term investments		253,000,000
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total assets fair value	0	0
Total liabilities fair value	$ 0	$ 0

Valuation of Debt and Equity Investments and Certain Liabilities - Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	$ 8,950	$ 5,961
Liabilities, fair value	395	350
Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	395	350
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	5,469	5,298
Liabilities, fair value	395	350
Level 1 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	395	350
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	3,481	663
Liabilities, fair value	0	0
Level 2 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	1,824	886
Money market funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	1,824	886
Money market funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	2,130	513
Corporate obligations \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Corporate obligations \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	2,130	513
U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	4,030	4,394
U.S. government and agency securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	3,629	4,394
U.S. government and agency securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	401	0
Non-U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	950	150
Non-U.S. government and agency securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Non-U.S. government and agency securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	950	150
Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	16	18
Mutual funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	16	18
Mutual funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	$ 0	$ 0

Postretirement Benefit Plans - Additional Information (Details) - USD ($) shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit pension plan formula, highest consecutive years of compensation (in years)	5 years
Length of time certain gains and losses are considered when determining the market-related value of assets related to the U.S. Qualified pension and retiree health care plans (in years)	3 years
Expected contribution to retirement benefit plans in next fiscal year	$ 10,000,000
Liability to participants of the deferred compensation plan	395,000,000
Deferred compensation plan assets	16,000,000
Defined Benefit \| Equity investments
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets directly invested in TI common stock	0
Retiree Health Care \| Equity investments
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets directly invested in TI common stock	$ 0
U.S.
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of company shares held by the U.S. defined contribution plans at year-end (in shares)	6	7
Value of the company shares held by the U.S. defined contribution plans at year-end	$ 1,160,000,000	$ 1,120,000,000
Dividends paid on the company shares held by the U.S. defined contribution plans at year-end	27,000,000	27,000,000
Aggregate expense for the U.S. defined contribution plans	63,000,000	61,000,000	$ 61,000,000
U.S. \| Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	820,000,000	992,000,000
Non-U.S.
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Value of the company shares held by the non-U.S. retirement plans at year-end	38,000,000	36,000,000
Non-U.S. \| Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	$ 2,470,000,000	$ 2,720,000,000
Defined contribution plan, also still accruing defined benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution (percent)	2.00%
Enhanced defined contribution plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution (percent)	4.00%
Defined contribution plan, employer fixed contribution (percent)	2.00%
Defined contribution plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer fixed contribution (percent)	2.00%

Postretirement Benefit Plans - Expense Related to Defined Benefit and Retiree Health Care Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 21	$ 18	$ 18
Interest cost	30	31	38
Expected return on plan assets	(31)	(36)	(41)
Amortization of prior service cost (credit)	0	0	0
Recognized net actuarial loss	15	7	9
Net periodic benefit costs	35	20	24
Settlement losses	13	16	10
Total, including other postretirement losses	48	36	34
U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Service cost	3	3	3
Interest cost	10	13	14
Expected return on plan assets	(9)	(12)	(14)
Amortization of prior service cost (credit)	(2)	(2)	(1)
Recognized net actuarial loss	0	0	0
Net periodic benefit costs	2	2	2
Settlement losses	0	0	0
Total, including other postretirement losses	2	2	2
Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Service cost	36	34	31
Interest cost	37	38	43
Expected return on plan assets	(81)	(78)	(86)
Amortization of prior service cost (credit)	1	1	1
Recognized net actuarial loss	7	14	29
Net periodic benefit costs	0	9	18
Settlement losses	2	1	3
Total, including other postretirement losses	$ 2	$ 10	$ 21

Postretirement Benefit Plans - Benefit Obligations and Plan Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Change in plan assets
Funded status at end of year	$ 303	$ 104
U.S. \| Defined Benefit
Change in plan benefit obligation
Benefit obligation at beginning of year:	1,097	960
Service cost	21	18	$ 18
Interest cost	30	31	38
Participant contributions	0	0
Benefits paid	(12)	(12)
Settlements	(162)	(94)
Actuarial loss (gain)	(79)	194
Plan amendments	0	0
Effects of exchange rate changes	0	0
Benefit obligation at end of year	895	1,097	960
Change in plan assets
Fair value of plan assets at beginning of year:	1,061	987
Actual return on plan assets	37	164
Employer contributions (qualified plans)	0	0
Employer contributions (non-qualified plans)	10	16
Participant contributions	0	0
Benefits paid	(12)	(12)
Settlements	(162)	(94)
Effects of exchange rate changes	0	0
Fair value of plan assets at end of year	934	1,061	987
Funded status at end of year	39	(36)
U.S. \| Retiree Health Care
Change in plan benefit obligation
Benefit obligation at beginning of year:	389	359
Service cost	3	3	3
Interest cost	10	13	14
Participant contributions	14	13
Benefits paid	(38)	(39)
Settlements	0	0
Actuarial loss (gain)	(18)	40
Plan amendments	0	0
Effects of exchange rate changes	0	0
Benefit obligation at end of year	360	389	359
Change in plan assets
Fair value of plan assets at beginning of year:	389	356
Actual return on plan assets	19	58
Employer contributions (qualified plans)	1	1
Employer contributions (non-qualified plans)	0	0
Participant contributions	14	13
Benefits paid	(38)	(39)
Settlements	0	0
Effects of exchange rate changes	0	0
Fair value of plan assets at end of year	385	389	356
Funded status at end of year	25	0
Non-U.S. \| Defined Benefit
Change in plan benefit obligation
Benefit obligation at beginning of year:	2,868	2,581
Service cost	36	34	31
Interest cost	37	38	43
Participant contributions	9	7
Benefits paid	(101)	(95)
Settlements	(12)	(8)
Actuarial loss (gain)	(111)	143
Plan amendments	0	1
Effects of exchange rate changes	(152)	167
Benefit obligation at end of year	2,574	2,868	2,581
Change in plan assets
Fair value of plan assets at beginning of year:	3,008	2,661
Actual return on plan assets	75	260
Employer contributions (qualified plans)	7	11
Employer contributions (non-qualified plans)	0	0
Participant contributions	9	7
Benefits paid	(101)	(95)
Settlements	(12)	(8)
Effects of exchange rate changes	(173)	172
Fair value of plan assets at end of year	2,813	3,008	$ 2,661
Funded status at end of year	$ 239	$ 140

Postretirement Benefit Plans - Amounts Recognized on our Balance Sheet (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	$ 392	$ 246
Accrued expenses and other liabilities & other long-term liabilities	(10)	(11)
Underfunded retirement plans	(79)	(131)
Funded status at end of year	303	104
U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	73	9
Accrued expenses and other liabilities & other long-term liabilities	(5)	(6)
Underfunded retirement plans	(29)	(39)
Funded status at end of year	39	(36)
U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	28	3
Accrued expenses and other liabilities & other long-term liabilities	0	0
Underfunded retirement plans	(3)	(3)
Funded status at end of year	25	0
Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	291	234
Accrued expenses and other liabilities & other long-term liabilities	(5)	(5)
Underfunded retirement plans	(47)	(89)
Funded status at end of year	$ 239	$ 140

- Definition

Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.

+ References + Details

Postretirement Benefit Plans - Schedule of Change in AOCI (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($)
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	$ 359
Adjustments, net actuarial loss	(231)
Recognized within net income, net actuarial loss	(37)
Tax effect, net actuarial loss	64
Total change to AOCI, net actuarial loss	(204)
AOCI balance, net actuarial loss portion (net of taxes), period end	155
Defined benefit plan amounts recognized in other comprehensive income prior service credit portion roll forward
AOCI balance, net prior service credit (net of taxes), beginning of period	(1)
Adjustments, prior service credit	0
Recognized within net income, prior service credit	1
Tax effect, prior service credit	0
Total change to AOCI, prior service credit	1
AOCI balance, net prior service credit (net of taxes), period end	0
U.S. \| Defined Benefit
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	125
Adjustments, net actuarial loss	(84)
Recognized within net income, net actuarial loss	(28)
Tax effect, net actuarial loss	23
Total change to AOCI, net actuarial loss	(89)
AOCI balance, net actuarial loss portion (net of taxes), period end	36
U.S. \| Retiree Health Care
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	(8)
Adjustments, net actuarial loss	(28)
Recognized within net income, net actuarial loss	0
Tax effect, net actuarial loss	6
Total change to AOCI, net actuarial loss	(22)
AOCI balance, net actuarial loss portion (net of taxes), period end	(30)
Defined benefit plan amounts recognized in other comprehensive income prior service credit portion roll forward
AOCI balance, net prior service credit (net of taxes), beginning of period	(2)
Adjustments, prior service credit	0
Recognized within net income, prior service credit	2
Tax effect, prior service credit	(1)
Total change to AOCI, prior service credit	1
AOCI balance, net prior service credit (net of taxes), period end	(1)
Non-U.S. \| Defined Benefit
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	242
Adjustments, net actuarial loss	(119)
Recognized within net income, net actuarial loss	(9)
Tax effect, net actuarial loss	35
Total change to AOCI, net actuarial loss	(93)
AOCI balance, net actuarial loss portion (net of taxes), period end	149
Defined benefit plan amounts recognized in other comprehensive income prior service credit portion roll forward
AOCI balance, net prior service credit (net of taxes), beginning of period	1
Adjustments, prior service credit	0
Recognized within net income, prior service credit	(1)
Tax effect, prior service credit	1
Total change to AOCI, prior service credit	0
AOCI balance, net prior service credit (net of taxes), period end	$ 1

Postretirement Benefit Plans - Plan Assets by Level Three Hierarchy (Details) - USD ($)
$ in Millions

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

$ 934

$ 1,061

$ 987

U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

385

389

356

Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

2,813

3,008

$ 2,661

Other | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

934

1,061

Other | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

375

360

Other | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

2,587

2,748

Level 1 | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Level 1 | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Level 1 | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

120

112

Level 2 | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Level 2 | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Level 2 | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

106

148

Fixed income securities and cash equivalents | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

655

743

Fixed income securities and cash equivalents | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

248

251

Fixed income securities and cash equivalents | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

2,220

2,278

Fixed income securities and cash equivalents | Other | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

655

743

Fixed income securities and cash equivalents | Other | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

238

222

Fixed income securities and cash equivalents | Other | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

2,045

2,063

Fixed income securities and cash equivalents | Level 1 | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Fixed income securities and cash equivalents | Level 1 | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Fixed income securities and cash equivalents | Level 1 | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Fixed income securities and cash equivalents | Level 2 | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Fixed income securities and cash equivalents | Level 2 | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Fixed income securities and cash equivalents | Level 2 | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

104

146

Equity securities | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

279

318

Equity securities | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

137

138

Equity securities | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

593

730

Equity securities | Other | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

279

318

Equity securities | Other | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

137

138

Equity securities | Other | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

^[1]

542

685

Equity securities | Level 1 | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Equity securities | Level 1 | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Equity securities | Level 1 | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Equity securities | Level 2 | U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Equity securities | Level 2 | U.S. | Retiree Health Care

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

Equity securities | Level 2 | Non-U.S. | Defined Benefit

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets

$ 2

[1]	Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents.

Postretirement Benefit Plans - Weighted Average Assumptions Used (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
U.S. \| Defined Benefit
Weighted average assumptions used to determine benefit obligations:
Discount rate (in percent)	2.74%	2.81%
Long-term pay progression (in percent)	3.70%	3.70%
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate (in percent)	2.95%	3.42%
Long term rate of return on plan assets (in percent)	3.50%	4.00%
Long-term pay progression (in percent)	3.70%	3.30%
U.S. \| Retiree Health Care
Weighted average assumptions used to determine benefit obligations:
Discount rate (in percent)	3.05%	2.74%
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate (in percent)	2.74%	3.63%
Long term rate of return on plan assets (in percent)	3.10%	3.50%
Non-U.S. \| Defined Benefit
Weighted average assumptions used to determine benefit obligations:
Discount rate (in percent)	1.57%	1.31%
Long-term pay progression (in percent)	3.15%	3.15%
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate (in percent)	1.31%	1.46%
Long term rate of return on plan assets (in percent)	2.82%	2.93%
Long-term pay progression (in percent)	3.15%	3.06%

Postretirement Benefit Plans - Weighted Average Allocations (Details)	Dec. 31, 2021	Dec. 31, 2020
Fixed income securities and cash equivalents \| U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	70.00%	70.00%
Fixed income securities and cash equivalents \| U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	64.00%	65.00%
Fixed income securities and cash equivalents \| Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	79.00%	76.00%
Fixed income securities and cash equivalents \| Minimum \| U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	65.00%
Fixed income securities and cash equivalents \| Minimum \| U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	65.00%
Fixed income securities and cash equivalents \| Minimum \| Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	60.00%
Fixed income securities and cash equivalents \| Maximum \| U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	80.00%
Fixed income securities and cash equivalents \| Maximum \| U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	80.00%
Fixed income securities and cash equivalents \| Maximum \| Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	100.00%
Equity securities \| U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	30.00%	30.00%
Equity securities \| U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	36.00%	35.00%
Equity securities \| Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	21.00%	24.00%
Equity securities \| Minimum \| U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	20.00%
Equity securities \| Minimum \| U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	20.00%
Equity securities \| Minimum \| Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	0.00%
Equity securities \| Maximum \| U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	35.00%
Equity securities \| Maximum \| U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	35.00%
Equity securities \| Maximum \| Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	40.00%

Postretirement Benefit Plans - Assumed Future Benefits Payments (Details) $ in Millions	Dec. 31, 2021 USD ($)
U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
2022	$ 89
2023	96
2024	87
2025	87
2026	87
2027 - 2031	391
U.S. \| Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
2022	28
2023	27
2024	26
2025	25
2026	24
2027 - 2031	108
Non-U.S. \| Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
2022	99
2023	101
2024	103
2025	105
2026	107
2027 - 2031	$ 566

Postretirement Benefit Plans - Health Care Cost Trend Rates (Details) - U.S. - Retiree Health Care	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Assumed health care cost trend rate for next year (in percent)	6.50%	6.75%
Ultimate trend rate (in percent)	5.00%	5.00%
Year in which ultimate trend rate is reached	2028	2028

Debt and Lines of Credit - Additional Information (Details)	1 Months Ended						3 Months Ended	12 Months Ended
	Feb. 28, 2021 USD ($)	May 31, 2020 USD ($)	Apr. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Sep. 30, 2019 USD ($)	Aug. 31, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2021 USD ($) seriesOfDebt
Debt Instrument [Line Items]
Commercial paper								$ 0
Repayments of debt								550,000,000	$ 500,000,000	$ 750,000,000
Proceeds from issuance of long-term debt								1,495,000,000	1,498,000,000	1,491,000,000
Interest and debt expense								184,000,000	190,000,000	170,000,000
Interest paid								$ 181,000,000	$ 182,000,000	$ 156,000,000
Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Repayments of debt	$ 550,000,000
Long-term debt stated interest rate (in percentage)								2.75%
Notes due 2026 at 1.125%
Debt Instrument [Line Items]
Principal amount											$ 500,000,000
Long-term debt stated interest rate (in percentage)								1.125%			1.125%
Notes due 2031 at 1.90%
Debt Instrument [Line Items]
Principal amount											$ 500,000,000
Long-term debt stated interest rate (in percentage)								1.90%			1.90%
Notes due 2051 at 2.70%
Debt Instrument [Line Items]
Principal amount											$ 500,000,000
Long-term debt stated interest rate (in percentage)								2.70%			2.70%
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Principal amount				$ 750,000,000
Long-term debt stated interest rate (in percentage)								1.375%
Payments of debt issuance costs				4,000,000
Proceeds from issuance of long-term debt				$ 749,000,000
Notes Due 2020 at 1.75%
Debt Instrument [Line Items]
Debt repaid			$ 500,000,000
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Principal amount		$ 750,000,000
Long-term debt stated interest rate (in percentage)								1.75%
Payments of debt issuance costs		5,000,000
Proceeds from issuance of long-term debt		$ 749,000,000
Notes due 2039 at 3.875%
Debt Instrument [Line Items]
Principal amount							$ 750,000,000
Long-term debt stated interest rate (in percentage)								3.875%
Payments of debt issuance costs							7,000,000
Proceeds from issuance of long-term debt							$ 743,000,000
Notes due 2020 at 1.75%
Debt Instrument [Line Items]
Debt repaid						$ 750,000,000
Notes due 2029 at 2.25%
Debt Instrument [Line Items]
Principal amount					$ 750,000,000
Long-term debt stated interest rate (in percentage)								2.25%
Payments of debt issuance costs					5,000,000
Proceeds from issuance of long-term debt					$ 748,000,000
Senior Notes
Debt Instrument [Line Items]
Number of series of debt issued \| seriesOfDebt											3
Principal amount											$ 1,500,000,000
Debt issuance costs											$ 10,000,000
Revolving credit facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity								$ 2,000,000,000

Debt and Lines of Credit - Schedule of Long-term Debt Outstanding (Details) - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total debt	$ 7,800		$ 6,850
Net unamortized discounts, premiums and issuance costs	(59)		(52)
Total debt, including net unamortized discounts, premiums and issuance costs	7,741		6,798
Current portion of long-term debt	(500)		(550)
Long-term debt	$ 7,241		6,248
Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.75%
Total debt	$ 0		550
Notes due 2022 at 1.85%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.85%
Total debt	$ 500		500
Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 500		500
Notes due 2024 at 2.625%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.625%
Total debt	$ 300		300
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.375%
Total debt	$ 750		750
Notes due 2026 at 1.125%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.125%	1.125%
Total debt	$ 500		0
Notes due 2027 at 2.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.90%
Total debt	$ 500		500
Notes due 2029 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 750		750
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.75%
Total debt	$ 750		750
Notes due 2031 at 1.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.90%	1.90%
Total debt	$ 500		0
Notes due 2039 at 3.875%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.875%
Total debt	$ 750		750
Notes due 2048 at 4.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.15%
Total debt	$ 1,500		1,500
Notes due 2051 at 2.70%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.70%	2.70%
Total debt	$ 500		$ 0

Leases - Component of Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Other long-term assets	$ 465	$ 319
Accrued expenses and other liabilities	82	72
Operating lease liabilities	$ 383	$ 249
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other long-term assets	Other long-term assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued expenses and other liabilities	Accrued expenses and other liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other long-term liabilities	Other long-term liabilities

Leases - Schedule of Operating Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Lease cost related to lease liabilities	$ 69	$ 70	$ 66
Variable lease cost	56	36	41
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for lease cost	61	59	60
Lease assets obtained in exchange for new lease liabilities	$ 210	$ 59	$ 167

Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2022	$ 84
2023	72
2024	60
2025	50
2026	45
Thereafter	214
Total	525
Imputed lease interest	(60)
Total lease liabilities	$ 465
Weighted average remaining lease term	9 years 2 months 12 days	8 years 10 months 24 days
Weighted average discount rate	2.51%	3.02%

Commitments and Contingencies (Details) $ in Millions	Dec. 31, 2021 USD ($)
Purchase Commitments
2022	$ 564
2023	436
2024	433
2025	43
2026	26
Thereafter	74
Total	$ 1,576

Supplemental Financial Information - Narrative (Details) $ in Millions	1 Months Ended	12 Months Ended
	Oct. 31, 2021 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) factory	Dec. 31, 2019 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring charges/other		$ 54	$ 24	$ (36)
Payments for restructuring		13	$ 8	$ 13
Cash consideration for acquisition	$ 893
Land acquired in Asset Acquisition	28
Buildings and improvements acquired in Asset Acquisition	305
Equipment and machinery acquired in Asset Acquisition	$ 526
Sherman and Dallas, Texas
Restructuring Cost and Reserve [Line Items]
Number of factories closing \| factory			2
Employee Severance \| Embedded Processing
Restructuring Cost and Reserve [Line Items]
Restructuring charges/other			$ 25
Payments for restructuring		$ 21

Supplemental financial information - Restructuring charges and other (Details) - USD ($)
$ in Millions

1 Months Ended

12 Months Ended

Oct. 31, 2021

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Disclosure Text Block Supplement [Abstract]

Restructuring charges

^[1]

$ 0

$ 25

$ (15)

Integration charges

^[2]

104

Gains on sales of assets

$ (50)

(50)

^[3]

(1)

^[3]

(21)

^[3]

Restructuring charges/other

$ 54

$ 24

$ (36)

[1]	Includes severance and benefits, accelerated depreciation, changes in estimates and other exit costs.
[2]	Includes costs related to our purchase of the Lehi, Utah, manufacturing facility, as well as ongoing costs until production begins in early 2023.
[3]	Includes a $50 million gain from the sale of property in October 2021.

Supplemental financial information - Restructuring balances (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Restructuring Reserve [Roll Forward]

Balance, January 1

$ 18

$ 0

$ 28

Restructuring charges

^[1]

(15)

Non-cash items

^[2]

Non-cash items

^[2]

Payments

(13)

(8)

(13)

Balance, December 31

$ 5

$ 18

$ 0

[1]	Includes severance and benefits, accelerated depreciation, changes in estimates and other exit costs.
[2]	Reflects charges for impacts of changes in exchange rates and accelerated depreciation.

Supplemental financial information - Other income (expense), net (OI&E) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Disclosure Text Block Supplement [Abstract]

Other income

^[1]

$ 145

$ 327

$ 201

Other expense

^[2]

(2)

(14)

(26)

Total

$ 143

$ 313

$ 175

[1]	Other income includes royalty and lease income, investment gains and losses, interest income, as well as reversals of tax interest accruals.
[2]	Other expense includes a portion of pension and other retiree benefit costs, currency gains and losses and miscellaneous items.

Supplemental financial information - Property, plant and equipment at cost (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 7,858	$ 5,781
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	132	125
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 3,490	2,571
Buildings and improvements \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	5 years
Buildings and improvements \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	40 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 4,236	$ 3,085
Machinery and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	2 years
Machinery and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	10 years

Supplemental Financial Information - Schedule of Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 4,362	$ 4,362
Goodwill impairment loss	0	0	$ 0
Analog
Goodwill [Line Items]
Goodwill	4,158	4,158
Embedded Processing
Goodwill [Line Items]
Goodwill	172	172
Other
Goodwill [Line Items]
Goodwill	$ 32	$ 32

Supplemental financial information - Other long-term liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure Text Block Supplement [Abstract]
Long-term portion of transition tax on indefinitely reinvested earnings	$ 403	$ 457
Deferred compensation plans	395	350
Operating lease liabilities	383	249
Other	186	249
Total	$ 1,367	$ 1,305

Supplemental financial information - Accumulated other comprehensive income (loss), net of taxes (AOCI) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ 13,333	$ 9,187
AOCI
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	(157)	(360)	$ (347)	$ (473)
Net actuarial loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	(155)	(359)
Prior service credit
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	0	1
Derivative instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ (2)	$ (2)

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

Supplemental financial information - Amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Other income (expense), net (OI&E)

$ 143

$ 313

$ 175

Provision for income taxes

(1,150)

(422)